SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD.ENVIRONMENTAL SOCIAL AND GOVERNANCE (ESG)

REPORT 2025Contents ABOUT THIS REPORT 01 01 REGULATING CORPORATE 09 02 STRICTLY CONTROLLING THE QUALITY 24

MESSAGE FROM THE CHAIRMAN 02 GOVERNANCE OF PRODUCTS AND SERVICES

Corporate Governance 10 Product Quality and Safety 25

ABOUT SNIBE 03 Corporate governance structure 10 Quality management system 25

Safeguarding shareholders' rights and interests 13 Product quality and safety management 29

SNIBE IN 2025 04

Milestones 04 ESG Governance 14 Focusing on R&D and Innovation 33

Key Performance 06 ESG governance structure 14 Ever-improving R&D and innovation system 33

Honors and Recognitions 08 Communication with stakeholders 14 R&D and innovation capability 35

Assessment of important issues 16 R&D and innovation results 39

Intellectual property protection 47

Compliance in Operation 20

Risk management and control 20 Supply Chain Management 48

Probity and self-discipline 20 Supplier management 48

Information security 22 Supplier communication 49

Sustainable supply chain management 50

03 Responsible Marketing 51PROMOTING GREEN OPERATION 58 Responsible marketing management 51Responsible brand building 52

Environmental and Occupational Health 59 Responsible marketing training 55

and Safety Management

Customer Service Quality 56

Addressing Climate Change 62 Customer service management and capabilities 56

Customer satisfaction 57

Green Operation 64 Improving customer service capabilities 57

Emissions and waste management 65

Resource and energy management 65

04 TALENT EMPOWERMENT 67 05 FULFILLING SOCIAL RESPONSIBILITY 81

Attraction and Retention of Talents 68 Industry Exchange and Cooperation 82

Diversity and equal employment 68 Industry-University-Research collaboration and 82

Employee rights and benefits 70 multi-center research

Employee care and communication 72 Academic extension 84

Driving industry standardization 86

Employee Training and Development 73 International exchanges and cooperation 89

Training system 73

Employee ability improvement 74 Community Commonweal 90

Employee promotion and development 76 Support for research and education 90

Supporting community commonweal 92

Occupational Health and Safety 78

Occupational health 78

Safety management 79

Key Performance Indicator Table 93

Appendix 98ABOUT THIS REPORT MESSAGE FROM THE CHAIRMAN ABOUT SNIBE SNIBE IN 2025 ABOUT THIS REPORT MESSAGE FROM THE CHAIRMAN ABOUT SNIBE SNIBE IN 2025

ABOUT THIS REPORT MESSAGE FROM THE CHAIRMAN

The year 2025 marks the conclusion of the 14th Five-

Year Plan and the in vitro diagnostics (IVD) industry faces

multiple challenges including the deepening of centralized

procurement cyclical adjustments and supply chain

restructuring. As an enterprise with the mission of "creating

value for human health" we firmly believe that the value of an

Overview > This is the fifth environmental social and governance (ESG) report issued by Shenzhen enterprise lies in upholding its original aspirations persisting

New Industries Biomedical Engineering Co. Ltd. According to the principles of objectivity in innovation and bravely assuming its responsibilities in the

standardization transparency and comprehensiveness this report discloses detailed information face of adversity. This year we have been working diligently

concerning the Company's practice and performance in the field of sustainable development in on standardized governance independent innovation green

2025 such as environment society and governance. operation and social responsibility and striving to write

a new chapter for Chinese IVD enterprises amidst industry

Scope of This report is an annual report and covers relevant data from Jan. 1 2025 to Dec. 31 2025. As some fluctuations.Reporting > of the data in this report involve continuity and comparability some contents are appropriately We have solidified the foundation for development

extended or traced as needed. through standardized governance. We firmly believe

that standardized governance is the cornerstone for an

This report covers Shenzhen New Industries Biomedical Engineering Co. Ltd. and its subsidiaries. enterprise to achieve steady and long-term development. In

line with the implementation of the new "Company Law of

Standards for This report is mainly prepared with reference to the "Global Reporting Initiative (GRI) Standards" the People's Republic of China" we have comprehensively

Reporting > "Shenzhen Stock Exchange Self-Regulation Guidelines for Listed Companies No. 17 - Sustainable revised the "Articles of Association" and several governance

Development Report (Trial)" "Shenzhen Stock Exchange ChiNext Self-Regulation Guidelines for systems added an employee representative director and

Listed Companies No. 3 - Sustainable Development Report Preparation" and the United Nations further optimized the governance structure of the board."Guide for Business Action on the Sustainable Development Goals (SDGs)" in order to continuously Facing the normalization of centralized procurement

improve the transparency of the disclosure of sustainable development reports and respond to the we have carried out rigorous audit supervision and anti-

commercial bribery efforts not only strictly controlling intelligent solutions.information needs of stakeholders. marketing compliance but also improving operational

efficiency through lean management. We place great We strictly control the quality lifeline and safeguard

Explanation > For better elaboration and understanding "Shenzhen New Industries Biomedical Engineering Co. importance on investor relations and during this period of t h e w e l l - b e i n g o f p a t i e n t s w i t h a s e n s e o f

Ltd." is also referred to as "Snibe" "We" or "the Company" in this report. industry valuation reshaping strive to convey the long-term responsibility. In the context of medical insurance cost

value of the Company's sound operations to the market control and centralized procurement price reduction

The monetary amounts in this report are measured in RMB unless otherwise specified. effectively protecting the rights and interests of shareholders we have always upheld the enterprise spirit of "Quality

especially small and medium-sized investors. is our life". We further strengthen the full lifecycle

Confirmation and This report was approved for release at the 7th Meeting of the 5th Board of Directors of the quality management system and continuously

Approval> Company on Apr. 27 2026. The Company and all members of the Board of Directors warrant that We adhere to innovation-driven development and define the enhance the traceability and risk prevention and

the contents disclosed in this report are true accurate and complete and that there are no false industry's standards through technological breakthroughs. control capabilities of the supply chain. What we

pursue is not only the accuracy of test results but also

records misleading statements or major omissions. Amidst increasingly homogenized competition in the industry

we focus on our strengths such as chemiluminescence to help reduce misdiagnosis rates and unnecessary

and continuously push the limits of single-machine speed medical expenses through technological innovation

Access to the This report includes paper and electronic versions. You can read and download the electronic measurement and detection accuracy. We continue to make so that every reagent and every instrument carries

Report and version of this report on Juchao Information Network (www.cninfo.com.cn) the designated breakthroughs in small molecule detection rare diseases the warmth of alleviating the burden of diagnosis and

Feedback > information disclosure website of the Shenzhen Stock Exchange or the official website of Snibe and the research and development of geriatric pediatric treatment for patients.(www.snibe.com) and obtain more company information. If you have any questions or suggestions and maternal products allowing innovative achievements

about this report please send an email to Snibeinfo@snibe.cn or call +86-755-86540062. to benefit a wider population. At the same time we keenly We promote green operation and respond to the

embrace the wave of "artificial intelligence + healthcare". By challenges of our time with low-carbon practices.This report is prepared in Chinese. The English version is the translation of the Chinese version. empowering R&D with digitalization we have significantly With increasing attention to sustainable development

If there is any ambiguity in the understanding of the English version the Chinese version shall improved both R&D efficiency and success rates. Our both domestically and internationally we continue

prevail. independently developed fully automated sample processing our efforts in energy conservation emission reduction

system SATLARS T8 prioritizes emergency cases and and resource recycling and continuously enhance the

features intelligent scheduling throughout the entire sample efficiency of energy and resource utilization through

testing process greatly shortening sample turnaround time technological equipment and method improvements.and helping laboratories improve quality and efficiency with We actively respond to China's carbon peaking and

01 02ABOUT THIS REPORT MESSAGE FROM THE CHAIRMAN ABOUT SNIBE SNIBE IN 2025 ABOUT THIS REPORT MESSAGE FROM THE CHAIRMAN ABOUT SNIBE SNIBE IN 2025

carbon neutrality strategy systematically promote greenhouse gas accounting and management and take concrete actions

to respond to the call for global climate change governance. SNIBE IN 2025

The kick-off meeting of "Multi-center Research on

We empower our employees to grow and unite organizational strength through diversity and inclusion. We always regard the Clinical Application of High-sensitivity Troponin I

talent as our most valuable core asset. We deepen the concept of diverse and equal employment improve the training system Concentration and Changes in the Assessment of Acute

and promotion channels establish a perfect salary and benefit system and incentive mechanism provide a comfortable Milestones > Myocardial Infarction" was successfully held

working environment and diverse welfare and take various welfare and care measures to create a highly sticky environment Cardiovascular disease is the "number one killer" that threatens

for talents enhance employees' sense of belonging and achievement and promote the common growth of employees and The multi-center clinical study on primary aldosteronism human health seriously endangering national health. Early

the Company. was concluded contributing to the screening and diagnosis and precise treatment are the keys to saving lives.treatment of hypertension This meeting focused on in-depth discussions on the precise

We fulfill social responsibility and give back to society's expectations with professional expertise. As a national enterprise diagnosis and treatment of myocardial infarction and the

leveraging our professional advantages we actively promote the allocation of high-quality medical resources to grassroots The "Conclusion Meeting of the Series of Studies on Diagnostic application of high-sensitivity troponin in emergency triage

Markers of Primary Aldosteronism and Seminar on the Current

levels. Through strategic partnerships with leading healthcare institutions we drive translational research to enable early injecting new momentum into the prevention and control of Status Challenges and Countermeasures of Primary Aldosteronism

diagnosis and treatment of chronic diseases and support medical education and talent cultivation. In the grand vision cardiovascular diseases. Diagnosis and Treatment" sponsored by the Laboratory and

for global healthcare we are committed to serving global health needs with intelligent manufacturing from China and Clinical Branch of the Chinese Society of Cardiothoracic and

contributing Chinese strength to building a healthier fairer and more sustainable future. Vascular Anesthesiology co-organized by the Chinese Endocrine

Hypertension Collaborative Group and organized by the Company

Sustainable development is an enduring journey. Guided by unwavering reverence for human life and health we harness was grandly held in Shenzhen. The conclusion of this multi-center

innovation to address evolving healthcare imperatives and uphold our corporate mission through responsible stewardship. research on primary aldosteronism screening has promoted the

Looking ahead we will continue to drive innovation and take responsibility forging new paths amidst change and working standardization of primary aldosteronism screening and diagnosis

hand in hand with every partner to write a brilliant chapter for Chinese IVD enterprises! in China.Chairman: Rao Wei

Apr. 27 2026

ABOUT SNIBE

Company Introduction > MAGLUMI X10 a flagship

fully-auto chemiluminescence

Since its founding in 1995 Snibe has focused on the field of IVD and developed itself into a national high-tech enterprise The project "Multi-center Research to immunoassay analyzer with a Biossays C10 an automatic

specializing in the R&D production sales and services of IVD products. Since its inception the Company has dedicated itself Establish the Reference Interval for throughput of 1000 T/H was biochemistry analyzer with a

to the mission of "customer-centric market-oriented creating value for human health through continuous innovation" to High-sensitivity Troponin I in Apparent certified for market launch throughput of 2000 T/H was

provide customers with better IVD products and services. After 30 years of profound development technology iteration and Healthy People in China" was successfully certified for market launch

customer accumulation the Company's products have broken the monopoly and technology blockade of overseas giants on concluded MAGLUMI X10 represents another

China's IVD market and Snibe has become a leader in China's IVD field and is evolving into a pioneer in the global IVD field. significant breakthrough for Snibe The launch of the Biossays C10

Laboratory testing of cardiovascular disease in the IVD field demonstrating demonstrates the Company's strong

Corporate Culture > biomarkers is susceptible to multiple factors and its leading strength in clinical R&D capabilities in ultra-high-speed

technologies suitable for precise testing are crucial application and technological biochemistry analyzers marking

for clinical decision-making. This multi-center innovation while also injecting new another major breakthrough in the

momentum and vitality into the field of biochemistry analyzers in

Mission Core values Vision Spirit research on reference interval extensively covers key factors affecting biomarker testing including global healthcare industry. China and moving towards a higher

Customer-centric market- Assume responsibility To be a leader in Quality is our life multiple regions diverse populations various level.oriented creating value for bravely China's IVD field ethnicities and different lifestyles. The research

human health through continuous Enjoy challenge persistentlyPursue excellence passionately To be a pioneer in the findings will open new paths for the prevention

innovation. global IVD field diagnosis and treatment of cardiovascular diseases

in China helping laboratory medicine better serve

people's health.Company's Ownership Structure >

As of the end of the reporting period the actual controller of Snibe is Mr. Weng Xianding whose direct shareholding ratio is

3.18% and shareholding ratio through Tibet New Industry Investment Management Co. Ltd. is 26.88% totaling 30.06%. The

second largest shareholder is Rao Wei the chairman and general manager of the Company with a shareholding ratio of

13.77%. The third largest shareholder is Tianjin Sequoia Juye Equity Investment Partnership (Limited Partnership) (hereinafter

referred to as: Sequoia Juye) with a shareholding ratio of 10.62% (as of the disclosure date of this report the shareholding

ratio of Sequoia Juye is 8.78%).

03 04ABOUT THIS REPORT MESSAGE FROM THE CHAIRMAN ABOUT SNIBE SNIBE IN 2025 ABOUT THIS REPORT MESSAGE FROM THE CHAIRMAN ABOUT SNIBE SNIBE IN 2025

Hemolumi H6 a high-speed automated The Company won the 2025 China Industry-University- Key Performance >

coagulation analyzer and Biossays E6 Plus Research Institute Collaboration Association Science and

a high-speed fully-auto electrolyte analyzer Technology Innovation Award

were certified for market launch

The Company in collaboration with top institutions such as Fuwai

The launch of Hemolumi H6 and Biossays E6 Hospital of the Chinese Academy of Medical Sciences Peking Economic performance

Plus marks another milestone for the Company University People's Hospital Fuwai Shenzhen Hospital of the

in the IVD field providing core laboratories with Chinese Academy of Medical Sciences and the Second Affiliated

more comprehensive solutions through modular Hospital of Hainan Medical University jointly conducted the project

integration into total laboratory automation systems. "Small Molecule 'Sandwich Method' Ushers in a New Era of Precise Net profit attributable to

Diagnosis for Primary Aldosteronism". With its groundbreaking Business revenue shareholders of listed companies Earnings per share

technological innovation and significant industry demonstration

value it won the third prize of the Innovation Achievement Award. 4576.76 Million 1620.25 MillionRMB 2.0621 RMB/shareRMB

Corporate governance

Proportion of employees Proportion of employees

Investor exchange Information disclosure receiving anti-commercial signing anti-commercial

assessment result

Nearly bribery training bribery commitments

300 activities A 100% 100%

The Company's key reagent

material and process R&D

Several small molecule "sandwich" Snibe R&D and Production team was awarded the title of

assay reagents were certified for Building officially commenced "Guangdong Provincial Advanced

market launch Collective" Quality of products and servicesconstruction

By the end of 2025 the Company's small The Company's Snibe R&D Building The Company's key reagent material

molecule "sandwich" assay reagents have Number of valid Number of globally available Quality management (also known as Snibe Phase V Project) and process R&D team was awarded the R&D investment

obtained a total of 15 product registration officially commenced construction in title of "Guangdong Provincial Advanced amount patents granted chemiluminescence system certificates

certificates. The detection technology is Collective" for its outstanding innovative immunoreagentsDec. 2025. Upon completion the project

becoming increasingly mature and the will further enhance the Company's strength and social contribution

service users have expanded from China R&D and innovation capability and demonstrating the Company's strength

in tackling core technologies. 477.77 Million RMB 426 250 3to the world. It is widely used in more production scale injecting new

than 100 countries and regions around momentum into the Company's global

the world helping to achieve precision development.diagnosis and treatment and contributing

to global healthcare.Overall satisfaction Total number of confirmed Number of events resulting Number of

with customer complaints received related to in fines or penalties for recalled products

complaint handling infringement of customer privacy breach of regulations

100%000

05 06ABOUT THIS REPORT MESSAGE FROM THE CHAIRMAN ABOUT SNIBE SNIBE IN 2025 ABOUT THIS REPORT MESSAGE FROM THE CHAIRMAN ABOUT SNIBE SNIBE IN 2025

Honors and Recognitions >

Attraction and retention of talents

Honor and recognition Issuing authority

Number of employees Proportion of female Proportion of females in Proportion of females in National High-tech Enterprise Science Technology and Innovation Commission of Shenzhen

employees management senior management Municipality Finance Bureau of Shenzhen Municipality and

Shenzhen Tax Service State Taxation Administration

2785 36.62% 30.27% 66.67% National Enterprise Technology Center National Development and Reform Commission

Master Enterprise of "Industry-Education-Assessment" Human Resources and Social Security Department of Guangdong

Skills Ecological Chain in Guangdong Province Province

Proportion of employees Proportion of employees Total training duration Social insurance coverage Listed in the "White List" of Shenzhen Entry-Exit Biomedical Development and Reform Commission of Shenzhen Municipality

with bachelor degree or covered by year-end Special Products Pilot Enterprises (Institutions) in 2025

above performance appraisal 96743 100% Top 500 Enterprises in Guangdong Province in 2025 Guangdong Provincial Enterprise Confederation and Guangdong 73.29% 100% hours Provincial Association of Entrepreneurs

Guangdong Provincial Advanced Collective (Key CPC Guangdong Provincial Committee and People's Government

Reagent Material and Process R&D Team) of Guangdong Province

Forbes Asia's Best Under A Billion 2025 List Forbes

China's Top 20 Most Competitive Pharmaceutical Listed HEALTHCARE EXECUTIVE Magazine

Companies in 2025

Environmental and occupational health and safety

Shenzhen's Fourth Batch of Industry-Education Development and Reform Commission of Shenzhen Municipality

Integration Enterprises and Shenzhen Education Bureau

Energy consumption Carbon emission Water intake intensity Volume of reject water Shenzhen Top 10 Model Platforms for Lifelong Human Resources and Social Security Bureau of Shenzhen

intensity intensity recovered Vocational Skills Training Municipality

0.0076 0.0373 0.5467 21679.7 Pingshan District Science Popularization Education Base Science and Technology Innovation Bureau of Shenzhen

tons of standard tons of CO 32 m /10000 RMB cubic meters Pingshan District

coals/10000 RMB equivalent/10000 RMB 2025 Employer of Excellence in Occupational Credit Guangzhou Best Check Human Resources Co. Ltd.Grade A in information disclosure appraisal (four Shenzhen Stock Exchange

Coverage of occupational Number of employee deaths due Investment in environmental and consecutive years)

health examination to work-related injuries occupational health and safety

2024 Golden Bull Award - The Most Valuable Investment China Securities Journal

100% 0 4.58 Awardmillion yuan

The 19th China ESG Top 100 Listed Companies Securities Times

Scored BBB in MSCI ESG Rating MSCI

Scored AA in Wind ESG Rating Wind Information Co. Ltd.Scored AA in CNI ESG Rating Shenzhen Securities Information Co. Ltd.Scored AAA in Sino-Securities Index ESG Rating Sino-Securities Index Information Service (Shanghai) Co. Ltd.Top 100 A-Share Listed Companies in ESG Performance 2025 Sino-Securities Index Information Service (Shanghai) Co. Ltd.Top 20 A-Share Listed Companies in ESG Performance in Sino-Securities Index Information Service (Shanghai) Co. Ltd.Pharmaceutical and Healthcare Industry 2025

07 08Corporate Governance ESG Governance Compliance in Operation

01 Corporate Governance

Corporate governance structure >

REGULATING CORPORATE The Company in strict accordance with the "Company Law of the People's Republic of China" the "Securities Law of the People's Republic of China" the "Code of Corporate Governance for Listed Companies in China" the "Rules Governing the Listing of

GOVERNANCE Shares on the ChiNext of Shenzhen Stock Exchange" and other relevant laws regulations normative documents and relevant requirements of China Securities Regulatory Commission and in consideration of the actual situations of the Company has

established a corporate governance structure consisting of a board of shareholders a board of directors and a management

Major issues team and formulated and improved the "Articles of Association" and other internal control rules and working procedures to

· Corporate governance guarantee the standardized operation of the corporate governance structure.· Investor relations

· Compliance in operation In addition the Board of Directors of the Company has set up four special committees: the Strategy Committee the Nomination

· Sustainable development management Committee the Remuneration and Assessment Committee and the Audit Committee and formulated corresponding working

· Communication with stakeholders rules which formed a relatively scientific and standardized governance system and effectively ensured the standardized

· Information security and privacy protection operation and sustainable development of the Company. Among them the Audit Committee as the core supervisory body

· Anti-commercial bribery and anti-corruption under the Board of Directors assumed the functions of the former Board of Supervisors during the reporting period in

· Anti-unfair competition accordance with the provisions of the new "Company Law of the People's Republic of China" further strengthening the internal

supervision mechanism and the Company's governance structure simplifying the decision-making process and improving

governance efficiency.Alignment with Sustainable Development Goals (SDGs)

Board of

Shareholders

Secretary of the Board Board of Special Committees of the

of Directors Directors Board of Directors

Board Office Strategy Nomination

Committee Committee

Snibe has always regarded robust and standardized corporate General Manager's General Audit

Remuneration and

Office Manager Committee Assessment Committee

governance as the foundation of sustainable development.We continuously improve the governance framework enhance Anti-Bribery Compliance Internal Audit

sustainable development management deeply integrate the concept Leading Group Department

of sustainable development into daily operations and actively

communicate with stakeholders to respond accurately to the concerns

of all parties. We continue to strengthen compliance management

build a comprehensive internal control system and conduct business Figure - Corporate governance structure

in an honest and self-disciplined manner providing a solid guarantee

for the steady and long-term development of the Company.

10Corporate Governance ESG Governance Compliance in Operation Corporate Governance ESG Governance Compliance in Operation

Convening of three meetings Composition of the Board of Directors and executive team

The Company convenes and holds shareholders' meetings in a standardized manner in strict accordance with the "Rules

for the Shareholders' Meetings of Listed Companies" the "Articles of Association" the "Rules of Procedure for Shareholders'

Meetings" and other regulations and requirements adopts the combination of on-site voting and online voting counts the Directors of Non- Independent Female Proportion of Proportion of female

votes of small and medium investors separately when considering major matters affecting the interests of small and medium the Board of independent director directors independent directors directors

investors and discloses the voting results of small and medium investors in a timely manner to ensure that all shareholders Directors director

especially small and medium shareholders enjoy equal status and are able to fully exercise their rights. 8 5 3 3 37.5% 37.5%

The Board of Directors is responsible to the Board of Shareholders and the Company convenes and holds the meeting of the

Board of Directors in strict accordance with the relevant provisions of the "Articles of Association" and the "Rules of Procedure

for the Board of Directors". Independent directors are independent of the actual controllers controlling shareholders and

other related parties of the Company and are able to make judgments and express opinions independently to effectively Executives Female executives Proportion of female executives

safeguard the interests of all shareholders especially small and medium shareholders. The directors of the Company

through continuous study familiarization and mastery of relevant laws and regulations are committed to safeguarding the 6 4 66.67%

best interests of the Company and all shareholders and perform their duties in a faithful honest and diligent manner.Three meetings held by the Company in 2025 were counted as follows:

Basic information about the Board of Directors and executive team

Board of Shareholders Meetings of the Meetings of special committees Meetings of

Board of Directors of the Board of Directors Independent Directors Expertise

Name Position Gender Age Remuneration

Twice 3 Industry Risk man- Accou- Law Marketing compositiontimes 7 times 3 times experience agement nting

Rao Wei Chairman and general Male 61 √ Basic salary + annual

manager performance bonus

Weng Heming Non-independent director Male 28 √ Not on the Company's

payroll

Rao Jie Non-independent director Female 37 √ √ Basic salary + annual

Diversification of the Board of Directors and executive team performance bonus

The Company's Board of Directors consists of 8 directors including 3 independent directors 1 employee representative Li Xu Non-independent director Male 51 √ Not on the Company's

director and 3 female directors. Members of the Board of Directors are highly experienced in fields such as biomedicine payroll

financial audit risk control and law respectively. Wu Qianhui Independent director Female 53 √ Fixed allowance for

independent directors

The executive team of the Company consists of 6 executives including 4 female executives. The team consists of professionals Shen Weihua Independent director Female 55 √ √ Fixed allowance for

in biomedicine finance marketing clinical testing etc. With a wealth of management experience the team is able to independent directors

capitalize on market opportunities and put into action effectively. The general manager and other executives are appointed Zhi Yi Independent director Male 46 √ Fixed allowance for

or dismissed by the Board of Directors. The general manager presides over the production and operation management of the independent directors

Company organizes the implementation of the resolutions of the Board of Directors and reports to the Board of Directors. He Xin Employee representative Male 29 √ Basic salary + annual

director performance bonus

The Company strictly abides by the "Code of Corporate Governance for Listed Companies" and has formulated the Ding Chenliu Deputy general manager Female 50 √ Basic salary + annual

"Remuneration Management System for Directors and Senior Management" to establish a scientific and reasonable chief financial officer performance bonus

remuneration structure and achieve a balance between incentives and constraints. The Remuneration and Assessment Li Tinghua Deputy general manager Female 48 √ Basic salary + annual

Committee of the Board of Directors is responsible for drafting the remuneration plan and assessment standards for performance bonus

the Company's directors and executives reviewing the performance of directors and executives and conducting annual Liu Haiyan Deputy general manager Female 46 √ √ Basic salary + annual

assessments of them and supervising the implementation of the remuneration of directors and executives in accordance performance bonus

with the "Working Rules of the Remuneration and Assessment Committee of the Board of Directors". The remuneration plan Zhang Lei Deputy general manager Female 43 √ √ Basic salary + annual

for directors is decided by the Board of Shareholders and the remuneration plan for executives is approved by the Board secretary of the Board of performance bonusDirectors

of Directors explained to the Board of Shareholders and fully disclosed. The basic salary of the Company's executives is

determined based on their positions within the company job responsibility level and ability level. The annual performance Yuan Jinyun Deputy general manager Male 39 √ √ Basic salary + annual performance bonus

bonus is directly linked to the Company's operating performance with the assessment based on the Company's annual

operating goals and the individual's annual performance evaluation indicators.

11 12Corporate Governance ESG Governance Compliance in Operation Corporate Governance ESG Governance Compliance in Operation

Safeguarding shareholders' rights and interests > ESG Governance

Information disclosure

Guided by investor needs and based on compliance Snibe attaches great importance to information disclosure discloses

relevant information in a truthful accurate timely fair and complete manner in strict accordance with relevant laws and

regulations as well as the requirements of the "Articles of Association" the "Information Disclosure Management System" etc.and actively fulfills its information disclosure obligations and the Company designates "China Securities Journal" "Securities

Times" "Shanghai Securities News" and "Securities Daily" as information disclosure newspapers and Juchao Information

Network (www.cninfo.com.cn) as the website for information disclosure so as to ensure that the vast number of investors can

obtain accurate information on an equal basis and in a timely manner. ESG governance structure >

In 2025 Snibe issued 95 announcements including 4 periodic reports and 91 temporary announcements. In the 2024-2025 A robust ESG management mechanism is pivotal for the top-down implementation of the company's sustainability strategy.annual information disclosure appraisal for listed companies on the Shenzhen Stock Exchange Snibe was awarded the According to relevant laws and regulations and the sustainable development governance requirements of listed companies

highest grade of "A (Excellent)" for the fourth consecutive year reflecting a high level of recognition of Snibe's information Snibe continues to refine its ESG governance framework and optimize internal sustainable management.disclosure by the regulatory authorities and the capital market.The Board of Directors serves as the supreme decision-making body for Snibe's ESG governance and is responsible for leading

Investor relations and supervising the Company's ESG initiatives and reviewing and approving ESG-related planning targets and policies.Snibe attaches great importance to communication with investors and strictly follows relevant laws and regulations as Subordinate to the Board the Strategy Committee is tasked with deliberating on ESG-related topicsr eporting periodically to the

well as the "Company's Investor Relations Management System". The chairman is responsible for leading investor relations Board on ESG performance providing guidance and recommendations for ESG implementation andm onitoring the execution

management affairs the secretary of the Board of Directors is the person in charge of investor relations management affairs of improvement plans.and the Office of the Board of Directors is the functional department of the Company's investor relations management. In

addition we continue to learn from excellent investor relations management experience constantly try to carry out investor Under the Strategy Committee there are the ESG Work Leading Group and the ESG Work Implementation Group. The ESG

relations management in a more effective way and ensure that all shareholders have equal access to information by opening Work Leading Group composed of the general manager and deputy general manager of the Company drives and monitors

up diverse communication channels. the implementation of ESG programs whilep roviding decision-support inputs to the Strategy Committee. The ESG Work

Implementation Group is led by the Office of the Board of Directors and the heads of various departments and subsidiaries

In 2025 we issued 12 record sheets of investor relations activities conducted regular briefings on performance reporting serve as team members and designated liaisons. This cross-functional team cooperates with various departments and

reverse roadshows and broker strategy meetings and organized nearly 300 investor exchange activities of various types. subsidiaries of the Company to implement ESG-related work and summarize the progress and performance of ESG-related

With the outstanding comprehensive strength and stable profitability we won the "Most Valuable Investment Award" at the work.

27th Golden Bull Awards for Listed Companies.

Communication with stakeholders >

Snibe always values and maintains effective communication with stakeholders. We fully consider the impact of our own

operations on all stakeholders understand the opinions suggestions and expectations of stakeholders by establishing a

regular communication mechanism and actively respond to the concerns of stakeholders which serve as the basis for the

Company's fulfillment of its responsibility for sustainable development.Stakeholder Issue of concern Form and manifestation of communication

Government and Addressing Climate Change Comply with national laws and regulations

regulatory agencies Compliance in Operation Improve the compliance management system

Anti-commercial bribery and anti-corruption Establish an anti-commercial bribery system

Product safety and quality Strictly control the product quality

Industry exchange and cooperation Create cooperation programs and platforms

Community commonweal Actively participate in government projects

Respond to government policies

Carry out charitable projects

13 14Corporate Governance ESG Governance Compliance in Operation Corporate Governance ESG Governance Compliance in Operation

Stakeholder Issue of concern Form and manifestation of communication Assessment of important issues >

Shareholders and Corporate governance Improve the corporate governance system Snibe attaches great importance to and continuously improves the identification management and analysis of important

investors Sustainable development management Improve the compliance management system issues and takes the concerns of various stakeholders as an important consideration in formulating sustainable development

Compliance in Operation Enhance risk management and control strategies so as to accurately and effectively respond to the issues of interest to stakeholders thereby providing an important

Investor relations Fulfill the obligation of information disclosure reference for identifying and managing risks and opportunities.Product R&D and innovation Organize and participate in investor exchanges

Product safety and quality Increase efforts in R&D and innovation This year we invited stakeholders to participate in the survey in the form of an online questionnaire to understand their key

Intellectual property protection Strengthen intellectual property management concerns covering all employees customers suppliers and partners shareholders and analysts media industry associations

governmental organizations non-governmental organizations etc. Guided by the "Double Materiality" principle that is

"Financial Materiality" and "Impact Materiality" we systematically evaluated and prioritized these issues.Customers Product safety and quality Strictly control the product quality

Product R&D and innovation Increase efforts in R&D and innovation

Information security and privacy protection Enhance customer privacy management Steps for assessing important issues

Responsible Marketing Maintain compliance in marketing

Anti-unfair competition Strictly abide by business ethics

Customer Service Quality Improve the service quality Results analysis and

Conduct customer satisfaction survey 1 Issue identification and update 2 Issue survey 3issue ranking

Suppliers and Product Quality and Safety Strictly control the product quality With reference to the "Shenzhen Following the "Double By comprehensively

partners Chain Management Strengthen supplier quality management Stock Exchange Self-Regulation Materiality" principle we considering the results of

Anti-commercial bribery and anti-corruption Organize supplier meetings and training Guidelines for Listed Companies invited stakeholders to peer benchmarking and

Equal treatment of SMEs Establish an anti-commercial bribery system No. 17 - Sustainable Development conduct a questionnaire stakeholder survey the issues

Intellectual property protection Strengthen intellectual property management Report (Trial)" (hereinafter referred to survey on the assessment of were assessed and analyzed

as the "Guidelines") GRI Standards "Financial Materiality" and from two dimensions: the

Employees Diversity and equal employment Organize employee care activities and other international standards "Impact Materiality". importance to the economy

Employee rights and benefits Establish communication channels for employees SDGs and outstanding practices in society and environment

Employee training and development Employees' Congress and Labor Union the industry and in combination and the importance to the

Occupational Health and Safety Provide diverse training programs with the Company's business growth Company's finance and

Develop a transparent promotion policy and ESG practices we identified the issues were ranked by

Improve the employee salary management and other important issues on the 21 importance.performance management system topics specified in the "Guidelines"

Establish the environmental and occupational of Shenzhen Stock Exchange

health and safety system and formed a list of topics after

comprehensive evaluation.Industry associations Product R&D and innovation Actively carry out industry exchanges

and professional Industry exchange and cooperation Create cooperation programs and platforms

organizations Provide practice and research bases

Community and Product safety and quality Strictly control the product quality

media Emissions and waste management Strictly control waste discharges

Industry exchange and cooperation Create cooperation programs and platforms

Community commonweal Carry out charitable activities

Biodiversity conservation Participate in volunteer service

Maintain good communication with the media

15 16Corporate Governance ESG Governance Compliance in Operation Corporate Governance ESG Governance Compliance in Operation

Matrix of importance issues For the seven issues with high financial materiality we further identified the associated risks and opportunities and assessed

the potential impact of these risks and opportunities on the Company's strategy decision-making financial condition

operating results cash flow and other factors in the short term (1-3 years) medium term (3-5 years) and long term (more

than 5 years). In addition for each issue the corresponding sections of this report will systematically disclose the Company's

Responsible Marketing Product safety and quality

Occupational health and safety Product R&D and innovation measures in monitoring prevention management control and mitigation of the impact.Information security and privacy Intellectual property protection

protection Compliance in operation

Anti-commercial bribery and anti-

corruption

Customer Service Quality

Financial Risks and impacts Opportunities and Impact Section of

materiality impacts time management

issues horizon measures

Product safety If product safety and quality Establishing a full lifecycle Short Product

Industry exchange and cooperation Sustainable development management Employee rights and benefits and quality management fails to consistently quality management system term Quality and

Environmental management Supply Chain Management meet regulatory requirements or is that is stricter than regulatory Medium Safety

Corporate governance inadequate it may lead to product requirements strengthening term

Anti-unfair competition recalls regulatory penalties and product competitiveness Long

Investor relations damage to brand reputation resulting through rigorous quality control term

Communication with stakeholders in customer loss and a decline in and quality management

Employee Training and Development market share. systems and enhancing brand

Emissions and waste management value and driving business

expansion by high-quality

products and services.Resource management

Energy management Product R&D The IVD industry is characterized by Conducting forward-looking Short Focusing

Diversity and equal employment and innovation rapid technological iteration. If the planning focusing on clinical term on R&D and

Equal treatment of SMEs innovation direction is disconnected needs developing innovative Medium Innovation

Community commonweal

Biodiversity conservation from market demand R&D investment solutions building technical term

Addressing Climate Change will fail to generate expected returns barriers exploring new Long

resulting in sunk costs missing markets through differentiated term

opportunities in emerging markets competition and creating new

lagging product line iteration revenue growth drivers.falling into homogeneous low-price

competition and ultimately leading to

a decline in profitability.Low Medium High Financial Materiality

Intellectual Negligence in intellectual property Establishing a sound intellectual Medium Focusing

property management and patent portfolio may property management system term on R&D and

protection lead to infringement and imitation of and patent portfolio building Long Innovation

core technologies which will weaken technical barriers protecting term

Environmental category Social category Governance category market pricing power and competitive core technologies from

moats. infringement and developing

Addressing Climate Change Product R&D and innovation Corporate governance new profit channels through

Emissions and waste management Product safety and quality Compliance in operation patent licensing and technical

Energy management Intellectual property protection Sustainable development management cooperation.Resource management Supply Chain Management Communication with stakeholders

Environmental management Customer Service Quality Investor relations Compliance in Against the backdrop of increasingly Building a sound compliance Short Compliance in

Biodiversity conservation Responsible Marketing Anti-commercial bribery and anti-corruption operation stringent global regulations in the IVD management system term Operation

industry any non-compliance may controlling compliance-related Medium

Information security and privacy protection Anti-unfair competition lead to financial losses and serious risks and maintaining excellent term

Diversity and equal employment violations may result in the business compliance records will help Long

Occupational health and safety being ordered to suspend operations tap into high-end overseas term

Employee Training and Development for rectification thereby undermining markets enhance customer

Employee rights and benefits the foundation of an enterprise's trust highlight management

Industry exchange and cooperation operation. advantages during industry

Equal treatment of SMEs reshuffling and thereby secure

Community commonweal a stable market share.

1718

Impact Materiality High Medium LowCorporate Governance ESG Governance Compliance in Operation Corporate Governance ESG Governance Compliance in Operation

Financial Risks and impacts Opportunities and Impact Section of Compliance in Operation

materiality impacts time management

issues horizon measures

Anti- The IVD industry involves hospital Establishing a sound anti- Short Compliance in

commercial procurement and distributor bribery management system term Operation

bribery and management making it a highly promoting a culture of Medium

anti-corruption sensitive field for corruption. integrity and compliance term Risk management and control >

Commercial bribery and corruption and continuously improving Long

incidents may bring significant and optimizing internal term We have established an internal oversight system in accordance with the relevant national laws and regulations and the

economic costs and legal management systems and "Notice on Strengthening the Internal Control Construction of Listed Companies and Proposed Listed Enterprises and Promoting

consequences to a company. processes can effectively reduce Internal Control Evaluation and Audit" the "Basic Standards for Internal Control of Enterprises" promulgated by the Ministry of

the risk of corruption. At the Finance and the "Guidelines for Internal Control of Listed Companies" issued by Shenzhen Stock Exchange and continuously

same time an integrity and optimized the "Manual for Internal Control Management" and the "Internal Audit Management System" providing guidance for

compliance brand image can internal audit supervision.lower marketing and market

entry costs. The Company has established a sound internal control and risk management framework. The Audit Committee is set up

under the Board of Directors which is responsible for the supervision inspection and evaluation of the Company's internal

Customer End customers in the IVD industry Leveraging digital services Short Customer control financial information and internal audit. Under the leadership of the Board of Directors and the Audit Committee of

service quality require continuous services such as responding to technical support term Service Quality the Board of Directors the Company has established the Internal Audit Department which is responsible for formulating and

instrument maintenance technical promptly enhancing customer Medium improving internal audit internal control and other internal management systems performing comprehensive risk assessment

support and result interpretation. stickiness and satisfaction term and monitoring of various business processes independently conducting internal audit and routine audit of all business

Slow after-sales service response or establishing a customer Long departments and subsidiaries of the Company every year forming audit reports and rectification proposals on the risk matters

inadequate technical support will feedback mechanism driving term identified through the audits continuously following up the implementation of rectification proposals assisting the audited

lead to a decline in end customer innovation and optimizing departments or subsidiaries in improving relevant business systems and risk management processes strengthening the risk

satisfaction directly cause equipment service experience continuously management capabilities of the departments and effectively reducing the risks in the Company's operation.suspension and declining reagent consolidating customer

sales and ultimately affect the relations and providing support To further enhance the collaborative efficiency of risk management the Internal Audit Department has gradually achieved deep

sustainability of the main business. for the long-term development integration of legal affairs compliance and internal control. By breaking down functional barriers and promoting information

of the business through high- sharing and data integration the accuracy of risk identification has been significantly improved. The legal function ensures the

quality services. legality and compliance of all business activities through contract review legal consultation and dispute resolution thereby

preventing legal risks at source. The internal audit function identifies operational risks through audit projects and supervises

Employee The IVD industry is highly dependent Building a diverse and inclusive Short Attraction and the implementation of corrective measures to ensure that the Company's operations comply with internal and external

rights and on the technology accumulation of work environment providing term Retention of regulations. The coordinated operation of these two functions comprehensively enhances the overall risk management and

benefits R&D personnel and the professional a competitive remuneration Medium Talents control level of the Company.promotion capability of marketing and incentives system career term

personnel. A lack of a competitive development opportunities and Long In 2025 the Internal Audit Department focused on three core pillars: marketing supply chain and corporate functions and

remuneration system and career health and safety safeguards term conducted comprehensive and in-depth audits by assigning dedicated auditors to focus on each pillar. This year we completed

development channels or the existence and establishing a strong audits of 8 offices in China visits to 156 distributors contract process management audits of 11 core functional departments

of employment risks may lead to the employer brand can attract visits and bidding for 36 projects and final account audits for 32 projects. From offices to distributors and from contract

loss of core talent affect product R&D high-quality talent in the processes to project settlements the Internal Audit Department is committed to promoting efficient resource allocation and

progress and market stability and industry stimulate innovation continuous process optimization through independent supervision and evaluation functions thus safeguarding the Company's

increase management difficulty and and motivation and improve sustainable development.operational costs. per capita productivity.Probity and self-discipline >

Snibe strictly abides by laws and regulations such as the "Anti-Unfair Competition Law of the People's Republic of China" the

"Criminal Law of the People's Republic of China" and the "Interim Provisions on Prohibition of Commercial Bribery" adheres to

the management concept of "compliance first" bases on the development strategy of "steady operation" and implements the

compliance culture of fairness integrity and "Do things right". We hold a "zero tolerance" attitude towards any form of bribery

and strictly prohibit any form of bribery in public or private during the course of business. In 2025 no cases of fraud were found

19 20Corporate Governance ESG Governance Compliance in Operation Corporate Governance ESG Governance Compliance in Operation

in the Company's internal audits and no internal or external reports of corruption were received. Supervision and improvement

According to the "Control Procedure for Internal Audit" "Control Procedure for Corrective Action and Preventive Action" and

Anti-bribery compliance management other system and procedure documents the Anti-Bribery Compliance Team has conducted continuous monitoring of the

The Company has established a comprehensive anti-bribery compliance management system. We have disclosed the "Snibe effectiveness of the design and implementation of the anti-bribery management system and self-rectified the defects and

Anti-Bribery Compliance Policy" on the Company's official website to clarify the Company's overall objectives policies and deficiencies. On the one hand the Internal Audit Department will regularly conduct internal anti-bribery compliance audits

requirements for anti-bribery compliance management. We have set up an Anti-Bribery Compliance Leading Group and according to the annual plan to identify system defects and deficiencies and urge the implementation of rectification. On

the other hand we will continuously optimize the system based on the improvement recommendations identified during the

formulated and implemented the "Anti-Bribery Compliance Management Handbook" as well as a series of compliance annual external surveillance audits to ensure the effectiveness of the system.management norms and control procedures to ensure the effective operation of the anti-bribery management system.The anti-bribery compliance team composed of Internal Audit Department and internal auditors of various departments The Company's official website publicly discloses the hotline email address and mailing address for reporting issues to

undertakes anti-bribery compliance functions. ensure that external stakeholders can conveniently and safely report problems. Physical complaint mailboxes without

surveillance coverage have been set up in public areas within the Company's headquarters campus to effectively protect the

Since successfully passing the ISO 37001 anti-bribery management system certification audit the system has been operating privacy of whistleblowers and encourage internal employees to exercise oversight in accordance with regulations. In addition

smoothly. We have closely monitored external regulatory developments promptly collected information and systematically to passively receiving reports the Internal Audit Department in conjunction with the General Manager's Office is responsible

optimized the system control procedures based on the latest anti-bribery policies and guidelines. To further enhance the for accepting on-site reports. Meanwhile the Internal Audit Department proactively collects feedback and complaints from

operational efficiency of the system and strengthen the ability of various departments to identify and respond to bribery risks the end of the business chain by conducting on-site visits to distributors and suppliers every year extending oversight to the

we comprehensively revised the "Control Procedures for Bribery Risks" and "List of Bribery Risks" during the reporting period front line of cooperation. For potential non-compliance identified through reported clues or audit findings the Internal Audit

making them more closely aligned with actual business scenarios and significantly enhancing their practical guidance thus Department will conduct investigations according to relevant procedures and requirements and make suggestions on whether

to take disciplinary measures based on the investigation results.laying a solid foundation for building a more resilient compliance defense line.Build a corruption-free environment Reporting channels

In order to enhance the anti-bribery compliance awareness and ability of employees we regularly conduct on-site anti-bribery

compliance training for all employees and provide special training to new employees management compliance team ● Official website of the Company: https://www.snibe.com/(Supervision and Reporting Module)

personnel in important positions such as marketing finance procurement and HR as well as external business partners. ● Address: Internal Audit Department Snibe Building No. 23 Jinxiu East Road Jinsha Community Kengzi

We regularly provide employees with publicity of anti-bribery laws and regulations cases and the Company's anti-bribery Street Pingshan District Shenzhen 518122

policies through the Company's official website internal mails OA system etc. As mandated by the "Employee Handbook" ● Email: audit@snibe.cn

● Tel.: +86-755-26706462

all employees are required to sign the "Letter of Commitment for Anti-Bribery Compliance" upon onboarding. Additionally

business partners must sign the "Letter of Commitment for Business Ethics" "Anti-Commercial Bribery Agreement" or other

equivalent anti-corruption documentation prior to commencing collaboration with the Company. Information security >

We advocate that our business partners join hands with us to maintain sufficient anti-bribery compliance communication and Snibe strictly abides by the "Data Security Law of the People's Republic of China" the "Cybersecurity Law of the People's

sharing to jointly build an honest transparent and incorruptible anti-bribery compliant environment and to share the value Republic of China" the "Administrative Measures for the Graded Protection of Information Security" and other national laws

created by compliant operation. regulations and industry norms fully assumes the responsibilities for information security entities and continuously deepens

the construction of information security systems. In 2025 the Company reported no information security incidents and no

In 2025 we conducted 14 anti-commercial bribery trainings for internal employees and business partners and 100% of leakage of customer employee and business partner information.employees have received the anti-commercial bribery training and signed anti-commercial bribery commitments.Information security management

The Company attaches great importance to information security management continuously deepens the construction of

With the growth of overseas business during the reporting period we organized targeted compliance training on information security management system and strengthens its own risk management and control capabilities. We have kept

international anti-bribery sanctions and export controls in the healthcare industry for the Company's directors executives improving internal management measures such as the "Snibe Information Security Management Policy" and the "Snibe

and key personnel in charge of overseas marketing to enhance their compliance awareness and risk prevention capability in Communication Security Management Specification" and further standardized the information security management system

conducting overseas operations. and management processes. In 2025 we initiated the formulation of relevant regulations for the security management of

business systems and servers to standardize the security management of application systems throughout their full lifecycle.This year the Company maintained the effectiveness of the ISO 27001 information security management system and

successfully passed the annual external audit. The Company's remote service system Snibe Link retained the certification of

"Level III of National Information Security Level Protection" while continuously expanding its information security compliance

coverage.Information security management mode

Cybersecurity Committee Executive entity External entity

Executives and relevant responsible IT Department Suppliers etc.persons of the Company

21 22Corporate Governance ESG Governance Compliance in Operation

Control and preventive measures

Through the combination of institutionalized management and normalized inspection the Company has improved its

information security protection capabilities.In terms of proactive management the Company applies technical means such as data loss prevention (DLP) system and ESM

storage medium management module to secure data. Through situation awareness testing we conduct security monitoring

on all servers and user traffic achieving 100% handling of abnormal alarms. By conducting system penetration testing

and bastion host audits we preemptively identify and mitigate potential cyber threats. We strictly implement a full-server

vulnerability scan and repair mechanism every six months to ensure timely closure of system vulnerabilities. Additionally we

have established a sensitive information retrieval mechanism for public cloud drives to proactively investigate unauthorized

storage activities and prevent data leakage risks at source. Following the comprehensive upgrade of the 360 Terminal Security 02

System we have achieved automatic daily updates of the virus database and forced distribution to terminals ensuring that

all employees' terminals are in the latest protection state and effectively improving the overall security baseline. Internal

employees access the wireless network through domain account authentication and visitors access the wireless network

through SMS verification code authentication to ensure secure wireless network access. STRICTLY CONTROLLING THE QUALITY

In terms of reactive management the Company comprehensively upgrades the terminal protection software implements

the network access authentication mechanism introduces the anti-tampering backup system and optimizes the network OF PRODUCTS AND SERVICES

partition access control policy to build a multi-layered and three-dimensional security and protection system. In terms of the

handling of emergency incidents the Company has developed an information security emergency response plan to clearly Major issues

define the response mechanism handling process and measures in case of emergency incidents. · Product safety and quality

· Product R&D and innovation

Furthermore the Company placesp aramount importance on information security awareness initiatives prioritizes employee · Intellectual property protection

security awareness enhancement as a critical component of its cybersecurity strategy and has carried out multi-dimensional · Supply chain management

and multi-tiered security training programs. We not only organize information security training for new employees to instill · Responsible marketing

proper information security practices from day one but also carry out special information security training for all employees · Customer service quality

every year. · Equal treatment of SMEs

Alignment with Sustainable Development Goals (SDGs)

Information security training

In 2025 the Company continued to prioritize cultivating employees' information security awareness and

comprehensively improve the digital security literacy of all employees. We adopted a blended teaching

model combining offline in-person training with online live streaming and interaction and systematically

organized a special campaign to raise awareness of information security. The training content closely

addressed the security pain points in real-world

work scenarios and carefully designed practical

course modules including phishing email

identification techniques key points of personal

information protection and demonstrations of

common attack methods. The event saw broad

participation from employees significantly

enhancing their overall security awareness and

prevention capability. It effectively improved "Quality is our life" is the consistent corporate spirit of Snibe. Guided

employees' ability to identify and handle by this belief we continuously optimize the quality management

information security threats laying a solid system increase R&D investment and equipment upgrades and

foundation for the Company to build a digital constantly improve product quality and supply chain security. Through

security defense line. persistent product and technical reformation we provide clinicians

with more accurate and reliable testing solutions continuously

creating value for human health.

23Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

Product Quality and Safety

Snibe has long held the spirit of "Quality is our life".Driven by the spirit Snibe continues to optimize the

quality management system increase investment in R&D

personnel and equipment and enhance product quality

and supply chain safety. Snibe aims to provide more

accurate and reliable testing products for clinical doctors

and create value for human health through continuous

innovation.Process Relation Diagram of the Quality Management System of the Company

External

Quality management system > Documents Quality

Manual Quality Management

Snibe has established the policy of "Quality is our life" and set strict quality objectives. Besides a systematic documented (Policy & Objective) System Guidelines

and well-developed quality management system an organizational structure with defined responsibilities has been in

place to clarify control requirements for the quality management process. Snibe has also continued to optimize and improve

the quality management system gaining recognition of its product quality management capability from stakeholders and Procedural documents

ensuring stable product quality and safety amidst rapid business development. Describe the operating

procedures of each process

Quality Assurance Department Key Reagent Material QC Department Material Inspection Department Reagent QC

Department Instrument QC Department and Component Inspection Department have been set up to ensure product quality

throughout the lifecycle. While strictly abiding by external policies such as the "Quality Management System Requirements" Quality documents & technical documents(including systems regulations

"Medical Devices - Quality Management Systems - Requirements for Regulatory Purposes" and "Good Manufacturing Practice specifications and DMR) Describe the specific

for Medical Devices" Snibe has formulated and implemented such internal management systems as the "Quality Manual" and operation of each element

"Control Procedure for Product Monitoring and Measurement" that encompass the quality management process specifications

for products and equipment use to realize quality manufacturing. Quality record

(including DHR'S QSR) Quality Management

System operational

evidence

Quality Management System Documentation Structure

25 26Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

To align with the Company's global expansion we enhanced our Quality Management System (QMS) by fully integrating multi-

regulatory compliance requirements building on the foundation of MDSAP regulatory alignment. This initiative culminated in

the development of a comprehensive "Quality Internal Audit Compliance Manual" which standardized internal audit protocols Regular updates and dissemination of regulations

and ensured systematic and efficient internal audits.In 2025 the Company conducted 9 regulation

With the expansion of the Company's IVD new product line business in order to ensure effective quality control of the newly knowledge sharing sessions based on regular

added product line the Company obtained ISO 9001 and ISO 13485 system certificates for coagulation products during the regulation update tracking focusing on key

reporting period. regulatory documents in the industry and carrying

out targeted dissemination of information such

as the List of In Vitro Diagnostic Reagents Exempt

Quality management system certification obtained: from Clinical Trials (2025) and the Guidelines

for Registration Review of Fully Automated

Chemiluminescence Immunoassay Analyzers

(2025 revision). These efforts ensured that relevant

ISO 9001 ISO 13485 MDSAP personnel could keep abreast of the latest regulatory requirements and accurately identify

Quality Management System Medical Device Quality Management Medical Device Single Audit the potential impact of regulatory updates on the

Certification System Certification Program Certification Company's quality management system providing

strong support for the compliance maintenance

and continuous improvement of the system.Internal audit of quality management system

The effective operation of the quality management system is not possible without a well-developed internal quality

management team. Snibe has set up internal audit groups according to the "Control Procedure for Internal Audit" and

appointed qualified group members. Internal auditors receive expertise and skill training on quality management system

standards and regulations and internal audit skills and methods. Moreover they are assessed to ensure that each can

accurately pinpoint and identify nonconformities or defects in the system.The Company conducts annual internal audits covering the entire product line to ensure compliance with ISO 9001 ISO Training on the control of operational documents in the quality

13485 EU IVDR and the China GMP for medical devices. For this reason the Company's management system is effectively management system

implemented and maintained and continuously improved.Improved quality management capabilities In 2025 the company conducted a total of 29

To improve the knowledge reserve of personnel in the Quality Assurance Department a total of 55 training sessions and training sessions related to document control

learning activities were completed throughout the year totaling over 12000 hours focusing on IVD supervision and including comprehensive document control

upper-level laws and regulations (such as unannounced inspection supervision and penalties) facility and equipment training training on key points of software

management R&D processes risk management hazardous chemical handling product registration and post-market document review and specialized training on key

surveillance. Through systematic learning and practice the professional knowledge and skill levels of department personnel points of process document review. The training

were effectively improved providing solid technical support and assurance for the operation of the Company's quality comprehensively enhanced the awareness and

management system. professional ability of personnel in document

suitability and standardization contributing to the

To strengthen the Company's quality management capabilities and promote the strict implementation of the relevant continuous improvement of the Company's quality

requirements of the quality management system in 2025 the Quality Assurance Department conducted a total of 110 training management system.sessions on quality management covering various aspects such as medical device regulations document control design

changes hazardous chemicals management equipment management risk management and post-market surveillance. The

trainees included relevant personnel of R&D production inspection marketing quality management and other departments.Through the above training sessions the expertise skill proficiency compliance awareness and risk prevention ability of

relevant personnel have been improved providing a solid quality management team for the Company's development.

27 28Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

Effective operation and continuous optimization of quality management system In overseas markets 120 products demonstrated exceptional performance in the

Snibe conducts comprehensive and independent evaluation through supervision and review by external auditors and EQA programs conducted by leading international accreditation bodies in 2025

continues to optimize the quality management system based on the assessment and on-site inspection results. including Bio-Rad EQAS RIQAS RCPA-QAP CAP RfB UK NEQAS DEQAS IFCC and

NGSP which also validated the reliability of the Company's products.In 2025 the Company underwent 13 quality management system audits from government regulatory agencies such as the In 2025 Snibe participated in the 25 Hydroxyvitamin D (25-OH Vit D) DEQAS

Guangdong Medical Products Administration and the Shenzhen Administration for Market Regulation as well as external and obtained the 2025-2026 Certificate of Proficiency. We also participated in

audit agencies such as TüV DEKRA and SGS including 8 audits by third-party certification agencies 2 audits on Good the certification programs for glycated hemoglobin by IFCC and NGSP achieved

Manufacturing Practice for Medical Devices and 3 audits on the Guidelines for Verification of Quality Management Systems for excellent results and obtained relevant certificates.Medical Device Registration covering the quality management systems of all final product manufacturing sites achieving a

100% audit pass rate.

Through internal and external audits to continuously track the operation of the quality management system the Company's

quality management system has achieved continuous optimization and quality management capabilities have been

continuously improved ensuring the high quality output of products.Product quality and safety management >

External quality assessment

External quality assessment (EQA) is a system for checking supervising and verifying the laboratory's performance in order Quality improvement of reference measurement laboratory

to maintain a high standard of practice and EQA results are largely dictated by the samples provided by the laboratory. To Snibe has built a professional quality management system for the reference measurement laboratory in accordance with

ensure the high-level performance of end users we encourage EQA participation by domestic and overseas end users which the international standards of ISO/ IEC 17025 and ISO 15195 passed the review by the China National Accreditation Service

in turn allows us to follow up on product quality safety and performance. for Conformity Assessment (CNAS) and obtained the accreditation certificate. Besides high-end measurement devices

and advanced reference materials at home and abroad have been introduced and reference methods issued by the

In the domestic market Snibe participated in 51 EQA programs organized by the National Health Commission in 2025 Joint Committee for Traceability in Laboratory Medicine (JCTLM) and national authorities have been adopted to ensure the

involving 235 items for evaluation and we have achieved a 100% pass rate in routine EQA for four consecutive years. By the metrological traceability of testing results. We work to build kit testing capacity for the reference measurement laboratory

end of 2025 all the registered chemiluminescence reagent projects approved by the National Health Commission have been and establish a registered internal testing platform in strict accordance with national/industry standards supporting product

involved in EQA programs. quality inspection.While playing an active role in the cooperative development of reference methods and the collaborative assignment of

reference materials Snibe has been a stakeholder member of the Joint Committee for Traceability in Laboratory Medicine

(JCTLM) and a corporate communication member of committees and working groups of the International Federation of Clinical

100%100%98.9%100%99.7%100%100%

Chemistry and Laboratory Medicine (IFCC) such as the Clinical Laboratory Management (C-TLM) the Standardization of

100.0% 98.8% Thyroid Function Tests (C-STFT) the Bone Metabolism (C-BM) the Apolipoproteins by Mass Spectrometry (WG-APO MS) and

the Commutability in Metrological Traceability (WG-CMT) driving the standardization and harmonization of related projects.

98.0% Participating in cooperative research on reference systems at home and abroad and strengthening peer exchanges will help

improve the accuracy and comparability of test results.

96.0%

By the end of 2025 Snibe has established more than 20 reference measurement procedures for vitamins therapeutic drug

monitoring non-peptide hormones enzymes etc. Among them 11 procedures have been approved by the China National

94.0% Accreditation Service for Conformity Assessment (CNAS) including 6 for enzymes 1 for 17-hydroxyprogesterone 1 for

25-hydroxyvitamin D3 1 for total thyroxine 1 for total triiodothyronine and 1 for testosterone. Among them three procedures

92.0% for enzymes (ALT CK α-AMY) have been included in the JCTLM reference measurement service list database. In 2025 the

EQA results for the reference measurement laboratory were announced and Snibe achieved excellent results in 8 IFCC-RELA

90.0% programs and 15 NCCL-EQARL programs applied with a satisfactory pass rate.

2022202320242025

In 2025 the Company's reference measurement laboratory passed a routine supervision review by the CNAS regulatory

● National Health Commission EQA Pass Rate ● Domestic Routine EQAS Pass Rate authority.

29 30Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

Improved product quality management capabilities Adverse events and product recalls

In 2025 the Company made a lot of efforts to improve internal quality control further improving its product quality The Company continuously tracks and monitors the occurrence of post-market adverse events while closely following updates

management capabilities. At the same time the Company also promoted a culture of quality management through various and changes in relevant domestic and international post-market regulations and industry standards. On this basis the

means to enhance employees' quality awareness. Company continuously optimizes and improves processes for post-market adverse event monitoring recalls and advisory

notices to comprehensively enhance the effectiveness of post-market supervision.The Company standardized the on-site audit management of external suppliers and established To guide organize and manage adverse event monitoring for medical devices the general manager is in charge of

on-site audit management regulations and corresponding audit guidelines. overall control and resource coordination. At the same time we have set up a steering group that brings together different

departments and developed the "Control Procedure for Adverse Event" and supporting procedures and documents to collect

To implement refined management of facilities/equipment/systems the Company established feedback on adverse events from medical institutions businesses regulatory authorities and other relevant parties in a timely

the "Management Regulations for Classification Critical/Facility/Equipment Systems" to manner.distinguish between critical and non-critical facilities/equipment/systems and redefine the

revalidation/qualification cycle. The Company regularly reports the regulatory situation to the Medical Device Adverse Event Monitoring Working Group. For

any adverse events that occur we strictly implement the investigation and evaluation process conduct in-depth analysis of

The Company optimized the organizational environment stakeholder needs and risk and potential product risks and regularly issue periodic risk assessment reports for medical devices. Through data analysis we

opportunity control procedures and established risk assessment criteria for the quality actively promote continuous improvement after product launch achieving continuous monitoring of the full product lifecycle.management system.Collect Investigate Analyze Report Follow-up

& Evaluate

Methods: Report to or Adverse event

2025 assembly skills competition ● Regulator systems or ● Investigate Adverse event notify the supporting notices ● Analysis of investigation authorized report

● Feedback and causes report representatives

To enhance the professional skills of the assembly team strengthen the awareness of quality and complaints ● Relevance under local

efficiency promote the spirit of craftsmanship and facilitate teamwork and experience exchange the ● Clinical experience evaluation adverse event

Company held the "Craftsmanship for Excellence Efficiency for Quality" assembly skills competition ● Academic literature ● Risk regulations

in 2025. Through this competition the Company promoted a quality culture and facilitated the ● Others assessment

implementation of quality culture and awareness.Response to adverse events

In addition the Company relies on the after-sales service stations in various regions to ensure a timely response within

24 hours after receiving customer complaints provide perfect after-sales service and quickly solve customer problems.

Information such as customer hotline email and fax is provided on product labels and the official website of the Company to

ensure that customers have sufficient channels to complain and inquire about product problems.The Company formulated the "Control Procedure for Feedback and Complaint Handling" specifying the critical workflow

milestones in feedback and complaint handling and the categories of feedback information so as to guide regional

professional engineers to investigate analyze and follow up on feedback and complaints in accordance with the

requirements of the procedure document.In 2025 100% of complaints received have been addressed.The Company formulated the "Control Procedure for Recall of Medical Devices" which was cross-linked with complaints

adverse events and post-market supervision. At the same time we timely analyzed investigated and evaluated the collected

Product label and traceability management information to ensure that a recall was readily initiated according to regional laws and regulations.In accordance with the "Control Procedure for Identification and Traceability" the Company has taken measures to prevent

identification mix-ups and misuse throughout the process of product implementation. We have established a unique device In 2025 Snibe had no product recall and received no regulatory warning or punishment on our product or service quality.identifier (UDI) for all medical devices we sell to ensure their traceability.

31 32Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

Reagent R&D platform

Snibe takes chemiluminescence immunoassay products as the core business. After nearly 20 years of continuous innovation

and accumulation we have mastered the core technologies such as antigen-antibody labeling technology magnetic sphere-

Focusing on R&D and Innovation antigen/antibody coupling technology and chemiluminescence reagent preparation technology and achieved revolutionary technological breakthroughs in the field of small molecules. The Company has established a complete reagent development

platform covering immunodiagnostics biochemical diagnostics immunochromatography molecular diagnostics

coagulation and other IVD areas.Guided by GB ∕ T 42061-2022 IDT ISO13485:2016 "Medical Devices - Quality Management Systems - Requirements for

Innovation is our lifeblood and core competitiveness. Regulatory Purposes" and the actual situation of the Company the Reagent R&D Department has formulated the "Control

Snibe works to improve our R&D capabilities through Procedure for Design and Development" to define requirements for every phase of new product design and development.continuous R&D process optimization so that we can Additionally department-specific processes and standards have been developed and continuously optimized for critical

create more innovative quality products continue to design and development stages including the commercial demonstration and project initiation planning process for reagent

develop a whole product lineup and constantly create products the process finalization and validation protocol for reagent products the R&D-to-production transition process

value for human health. for reagent products and the design change control process for reagent products to standardize the management of new

product development process.Given the large number of projects and abundant information in the rapidly-changing IVD reagent market it is important to

identify key customer needs. We need to do the right thing in the business environment. To better serve the market with precise

provision of necessary products our reagent R&D team adheres to the strategies of "market-oriented product development"

Ever-improving R&D and innovation system > and "lifecycle business demonstration" and establishes a decision support mechanism for project initiation. In this way we

can determine whether a project meets market demand and is available for initiation and delivery.Instrument R&D platform The business demonstration process is shown below:

The Company has built and kept optimizing the product lifecycle management platform in line with its own characteristics.Through standardization process and data-based management we have improved the reliability predictability and

compliance of R&D projects enabling product development to be more robust and efficient. After years of practice and

iteration our R&D management platform has become increasingly mature providing strong support for product innovation

quality improvement and market competitiveness so that the Company can continuously launch high-quality products that

meet customer needs and market expectations.Intelligent data management Systematic process End-to-end quality

to improve R&D collaboration control to improve project control for product

efficiency execution excellence

We have built an efficient data We have implemented robust Supported by the R&D

management architecture to achieve process controls across critical management platform

centralized storage intelligent product lifecycle phases we can systematically

association and dynamic updates covering product definition manage product quality

throughout the product lifecycle. Our engineering change and including design verification

business teams can work together based version management to engineering change

on the single source of truth to ensure ensure the transparency tracking and quality

information integrity and accuracy and standardization and system compliance to

reduce redundancy and communication traceability of the processes at ensure that products meet

costs. At the same time data traceability all stages effectively reduce industry regulations and

and version management capabilities of development risks and shorten high standards and further

the system have been optimized which the product launch cycle. improve product stability and

allows the efficient reuse of research safety.and development results and facilitates

knowledge accumulation and innovation

breakthroughs.

33 34Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

R&D and innovation capability >

After more than 20 years of hard work Snibe has built a mature R&D system that spans the entire industry chain. There are four In 2025 our R&D investment was a year-on-year increase of accounting for

technology platforms targeting the R&D of magnetic microspheres key reagent materials diagnostic reagents and automatic

diagnostic instruments. 477.77 million yuan 5.33% 10.44%

of our revenue.Over 30 years of technology R&D capability enhancement

accumulation Recombinant protein expression ● Improvement of instrument R&D capabilitiesMagnetic Key reagent

Proprietary magnetic Antibody preparation The research and development of IVD instruments is a highly integrated work covering electronics mechanical engineering microspheres material R&D

microsphere preparation Protein and small molecule R&D technical technical software engineering and many other fields. We are committed to building an industry-leading R&D system continuously

technology platform platform modification improving our core competitiveness and developing more breakthrough IVD instrument products. To this end we have made

One of the few manufacturers Primer and probe synthesis constant efforts to deepen and improve our R&D capabilities in the following five areas.with such an advanced R&D

platform in the industry

R&D Strengthening We actively foster an open R&D ecosystem by establishing long-term cooperative relations

platform Reagents for chemiluminescence interdisciplinary with universities and research institutions driving the application-driven translation of immunoassay biochemical cooperation cutting-edge technologies. For example we set up a postdoctoral innovation practice base

Microelectronics R&D IVD IVD reagent analysis nucleic acid analysis and and technology and bring experts from different disciplines into R&D projects. Through interdisciplinary

Software R&D instrument R&D coagulation analysis integration collaborative innovation we continue to expand the boundaries of technology and accelerate

Mechanical design and R&D technical Technical CNAS-accredited reference the implementation of new technologies in instrument research and development.manufacturing platform platform laboratory

Stakeholder Member of the Joint Building a We have established a complete intellectual property management and protection system

Committee for Traceability in systematic covering patent applications technical confidentiality and intellectual property risk

Laboratory Medicine intellectual property management and control. The Company has a dedicated intellectual property management

management team responsible for the evaluation and protection of technological achievements to

system ensure that innovative achievements are legally and effectively safeguarded. At the same

time through regular training and internal publicity we raise R&D personnel's awareness

of intellectual property and promote the continuous generation of high-value patents and

R&D investment and team building software copyrights.Snibe has maintained friendly exchanges and communication with key universities and developed long-term on-campus

recruiting plans to ensure a steady stream of talents. At the same time Snibe has been recruiting social talents and Stimulating We advocate an innovation-driven development model and encourage R&D personnel to

independently training R&D professionals and persons in charge. By far it has built an efficient and high-quality team that innovative thinking keep an open mind and dare to challenge the traditional technology path. The Company

identifies with corporate culture. and cultivating provides sufficient experimental resources and exploration space for the R&D team supports

exploring spirit cutting-edge technology research and new product concept verification and encourages

By the end of 2025 we have engaged 781 R&D professionals accounting for 28.04% of the total number of employees. Among continuous optimization of product design from experiment and iteration to promote

them 97.57% are aged 40 or below and 49.68% have a master's or doctor's degree. A young and high-quality R&D team is technological breakthroughs.contributing to our R&D and innovation.Improving We have built a multi-level innovation incentive system including project meritorious

the incentive service award technology innovation award patent incentive plan and promotion incentive

mechanism and mechanism to fully stimulate the creativity of the R&D team. Meanwhile the Company

creating a culture of advocates a proactive and scientific R&D culture and supports technology exploration and

30 years old or below Bachelor's degree or below

75.29% 50.32% innovation innovation experiments within a reasonable range. Under a strict quality control system we empower the R&D team to systematically advance product solutions through data analysis

Educational and experimental verification and promote technological progress while ensuring product 31-40 Master's degree

Age distribution background safety and reliability.22.28% of R&D 48.66% distribution of

personnel R&D personnel Increasing R&D We insist on large R&D investment providing advanced equipment and perfect experimental

41 years old or above Doctor's degree investment and conditions for instrument R&D. In 2023 Snibe completed the Phase III construction of R&D

2.43% 1.02% consolidating the Building creating a better office and experimental environment for the R&D team and further

technical foundation enhancing the overall strength of instrument R&D and industry competitiveness.

35 36Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

During the reporting period the Company's instrument R&D team continued to improve the R&D governance system focusing ● Reagent R&D capability enhancement

on the goals of high-quality development and sustainable innovation. We deeply integrated digital R&D tools data-driven In 2025 to drive the synergistic improvement of R&D product quality efficiency and sustainability our R&D system driven

decision-making and cross-departmental collaboration mechanism into the full product lifecycle management. By combining by processes and systems established standardized and visualized R&D management systems and a knowledge base

cutting-edge technologies and scientific methodologies we built an agile efficient green and sustainable innovation center. This system encompasses the full product lifecycle including key milestones such as project initiation review design

ecosystem. This transformation further enhanced the technical barriers and quality excellence of our products helping the acceptance design and development transfer and product registration. Through continuous process/system iteration it

Company maintain its leading position in industry competition. identifies best practices in the product development process and achieves the greatest balance between product quality

and efficiency.Improving the R&D * We incorporated digital design virtual validation and cross-disciplinary review mechanism In terms of R&D personnel cultivation professional skills training was provided to employees based on the needs of

management and into the R&D project management process and quality control nodes to strengthen the different positions in the R&D department. In 2025 the Reagent R&D Department conducted a total of 213 training sessions

quality control institutionalization and traceability of the R&D process. including project experience sharing professional basic knowledge explanation and the use of professional tools to

system * We established a joint review mechanism covering multiple functional roles such as R&D help R&D personnel consolidate their theoretical foundation and master core operational skills. For new employees in

testing process quality and after-sales service to improve the governance capability and the Reagent R&D Department the Company developed a systematic training plan. In 2025 a total of 169 professional

decision-making transparency of complex projects. skills enhancement courses were delivered providing strong support for the growth of new employees ensuring talent

* We continued to advance the mechanism for accumulating R&D knowledge assets and availability for the efficient operation and sustainable development of the department and laying a solid foundation for

systematically managed historical project experience test data and improvement records to the Company's reagent R&D capability enhancement.support the organization's long-term learning and capability accumulation.* We integrated the concepts of green design and resource conservation into R&D

management requirements guiding projects to simultaneously focus on material utilization ● Improvement of R&D capabilities in key reagent materials

manufacturability and maintenance convenience during the design stage. Through relentless technological innovation and product development the Company has achieved groundbreaking

advancements in the field of small molecules. The key reagent material R&D team has established the R&D platform

Digital (I) Digital design and virtual validation for anti-neoepitop antibodies (antibodies that form new epitopes after the complexation of small molecule antigens

empowerment and * In the conceptual design and scheme demonstration stages 3D modeling and virtual with their specific antibodies). Such breakthrough has accelerated the development of the Company's small molecule

collaborative R&D prototype technology were routinely applied to carry out system-level layout interference immunization project. The result of small molecule sandwich assay is highly consistent with that of mass spectrometry

practices checks and assembly feasibility analysis in advance. which well compensates for the shortcomings of the competition method. The registration of 16 small molecule dual-

* Through an online review platform multi-disciplinary collaborative reviews were organized antibody sandwich assay reagents including 25-hydroxyvitamin D aldosterone estradiol progesterone testosterone

to achieve visual display and efficient communication of the design scheme. androstenedione tacrolimus vitamin B12 folic acid free triiodothyronine total triiodothyronine free thyroxine total

(II) Simulation analysis and data-driven optimization thyroxine reverse triiodothyronine cyclosporine and angiotensin I has been completed.* A closed loop of simulation analysis and measurement validation was carried out in key

modules to continuously optimize design parameters.* Standardized test schemes and closed-loop problem management processes were In terms of antibody preparation the Company has established a single-B cell preparation technology platform to drive the

established shifting quality risks forward to the design and validation stages. high-quality development of rabbit monoclonal antibodies and other novel antibodies thereby further improving reagent

(III) Collaboration between 3D technology and manufacturing performance significantly shortening the development cycle for primary antibodies in small molecule projects and

* Assembly simulation and process validation were applied to reduce repeated modifications improving the overall quality of antibody development. At present the Company has realized the self-production of iron

to prototypes and lower resource consumption. powder a key component of the magnetic sphere which helps to control the quality of in-house iron powder and reduce

* During the mass production preparation stage joint review of R&D and manufacturing was its batch-to-batch variability. Thus the supply problem of iron powder was solved the cost of the kit was further reduced

promoted to improve process maturity. and the market competitiveness and product accessibility were improved. In addition the Company has kept increasing

(iv) Agile R&D and cross-departmental collaboration investment in personnel and equipment for the research and development of key reagent materials so as to improve the

* By adopting a phased review and short-cycle iteration model the pace of problem R&D capabilities of key reagent materials.identification and resolution was accelerated.* By incorporating end-user feedback and after-sales experience into R&D improvement

inputs product reliability and maintainability were continuously optimized.In 2025 relying on the in-depth practice of the instrument R&D governance mechanism the Company's instrument R&D

capabilities and quality robustness continued to improve. On the decision-making side R&D decisions became more data-

driven and the ability to identify risks at the front end was significantly enhanced; on the execution side the trend of design

rework and repeated trial production was effectively controlled and the efficiency of R&D resource utilization was continuously

optimized; on the product side reliability manufacturability and maintainability were continuously improved; in terms of

team collaboration cross-departmental collaboration became smoother the pace of project progress and the efficiency of

problem closure were further improved and the ability to develop digital and complex systems was significantly enhanced.This series of advancements signifies that the Company's instrument R&D system has acquired high-quality sustainable

endogenous growth momentum.Gas Chromatograph Fully Automated Synthesis Workstation

37 38Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

R&D and innovation results >

With the original intention of "making medical examinations more affordable for the public" Snibe has pursued independent Biossays C6/Biossays C6P

innovation while developing our core business as a socially responsible employer. We work to create value for human health Automatic Biochemistry Analyzer

thus making quality medical resources available to all.Biossays C6/Biossays C6P are mid-to-high-end automatic

Instrument R&D results biochemistry analyzers under development by the Company.Thanks to enhanced R&D efforts we have delivered a lineup of instruments with increased accuracy and efficiency providing The biochemical module has a throughput of 1000T/H. For

reliable data for clinical diagnosis and promoting the accessibility of medical resources. Among them the SATLARS mini-T8 the electrolyte testing module Biossays C6 is equipped

Laboratory Automation System and the Biossays C6/Biossays C6P Automatic Biochemistry Analyzer are the company's key with a self-developed direct method electrolyte module

instrument products under development in 2025. These two products aim to reduce the affordability of medical terminals and with a throughput of up to 500T/H while Biossays C6P is

improve testing efficiency. equipped with an indirect method electrolyte module with

a throughput of up to 600T/H meeting the requirements of

different terminals.Both analyzers support direct loading of whole blood

without pretreatment enabling efficient clinical diagnosis.Adopting a modular design they can be interconnected

SATLARS mini-T8 with the MAGLUMI X6 chemiluminescence immunoassay

Laboratory Automation System analyzer to form a biochemical immunoassay automation

system. They also support connection to a total laboratory

SATLARS mini-T8 is an intelligent assembly line designed for compact spaces in the laboratory department. It highly integrates

automation system better meeting the needs of large-scale

sample pre- and post-processing functions enabling unattended automated operation from sample loading to testing

terminals.storage and disposal.No additional scattered pretreatment or transfer equipment is required effectively solving the pain points of equipment clutter

and low space utilization in the laboratory department and reducing manual transfer and handover steps by more than 80%.Equipped with AI vision-based serum quality identification and automatic quality control functions it eliminates problems such SATLARS T8

as sample contamination missed or erroneous testing and information entry deviations at source significantly streamlining Laboratory Automation System (aliquoter module added)

the operation procedures of the department improving sample turnaround efficiency and helping the laboratory department

SATLARS T8 is an open automation system developed by Snibe with completely independent intellectual property rights. It

achieve standardized intelligent and efficient operations of samples.fully integrates the five modules of biochemistry immunoassay electrolyte coagulation and molecule. The whole process of

sample loading transport processing testing and storage is automated greatly reducing manual intervention and improving

testing efficiency. The unique two-way four-track design makes sample scheduling more flexible toward dynamic balance.Modular design and multi-type tracks can be adapted to different laboratory spaces and meet different testing requirements

through flexible configuration. Emergency priority and intelligent scheduling can greatly shorten the TAT of samples. A

specialized data processing and information management system can help departments realize better quality management.The development of the SATLARS T8 aliquoter module was completed in 2025.

39 40Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

In 2025 the Company's integrated biochemical and immunoassay analyzer Biolumi CX10 was a finalist in the International Diabetes is a highly prevalent chronic disease worldwide. According to the 2021 report by the International Diabetes

Design Excellence Award (IDEA) and the Company's electrolyte analyzer Biossays E6Plus won the Gold Award at the French Federation approximately 537 million adults worldwide have diabetes and this number is projected to rise to 784 million by

Design Award. The two design awards stand as a strong testament to the innovation capabilities of our instrument R&D team 2045. China has the largest number of diabetes patients in the world with approximately 140 million patients accounting

and the growing global influence of our brand. These two products are also the first products to receive such awards. for about 26% of the global total. To improve the diagnosis rate of diabetes the Company developed an anti-zinc transporter

8 antibody (Anti-ZnT8) assay kit (magnetic particle based chemiluminescent immunoassay) during the reporting period.

According to the positive rate of glutamic acid decarboxylase antibody (GADA) in the population with newly diagnosed classic

type 1 diabetes mellitus (T1DM) in China the combined detection of protein tyrosine phosphatase antibody (IA-2A) and Anti-

ZnT8 can increase the positive rate by 10% to 15%. The launch of the Anti-ZnT8 product effectively fills the diagnostic gap

improves the detection efficiency promotes the precise subtyping of T1DM and enables early warning and individualized

treatment decisions.In the cardiovascular field Snibe successfully developed the 11-dehydrothromboxane B2 assay kit (magnetic particle based

chemiluminescent immunoassay) based on the small molecule sandwich technology R&D platform. Leveraging the technical

advantages of small molecule sandwich materials and methods it breaks through the sensitivity limitations of traditional

ELISA quantifies the degree of platelet activation accurately identifies patients with biochemical resistance provides a basis

for intensive intervention in high-risk populations and guides the adjustment of medication regimens. The kit is also suitable

for primary healthcare institutions enabling screening and triage of low-risk patients at the grassroots level thereby freeing

up resources at Grade A tertiary hospitals and implementing tiered diagnosis and treatment. It directly serves the core goal of

the "Healthy China 2030" initiative to reduce the mortality rate of cardiovascular diseases.Promoting the R&D of geriatric pediatric and maternal products

The Company actively responds to the requirements of documents like the national "Healthy China 2030 Planning Outline" the

Reagent R&D results "State Council's Opinions on Implementing Healthy China Initiative" the "14th Five-Year Plan for National Health" and WHO

During the reporting period the Company completed the registration of 9 new chemiluminescence reagents and 9 new initiatives to promote the research and development of geriatric pediatric and maternal diagnostic products.biochemical reagents which enriched the Company's reagent type in autoimmune antibodies liver fibrosis and infectious

diseases. The global treatment cost for Alzheimer's disease (AD) is projected to reach $1.89 trillion by 2050. Early screening and

diagnosis can slow disease progression reduce the need for mid-to-late stage care and help achieve the goal of "healthy

Attention to rare diseases aging". To this end the Company has carried out the R&D of cerebrospinal fluid and blood detection products related to AD

Snibe focuses on the study of rare diseases. We actively develop relevant products so that the life and health of patients with helping to comprehensively promote the prevention and control of dementia in the elderly. As of the end of the reporting

rare diseases are guaranteed. In addition to the rare diseases previously disclosed the rare diseases we are working on during period the Company had completed the development of multiple AD blood test kits (Aβ1-40 Aβ1-42 p-Tau-181 p-Tau-217

the reporting period are as follows: etc.) which are of great significance for the prevention and control of AD. First this technology breaks through the bottleneck

of early identification. Cerebrospinal fluid testing and PET scans are invasive expensive and difficult to popularize while

blood-based neurological biomarker testing with its high sensitivity and specificity non-invasiveness and cost-effectiveness

has become the key to breaking the deadlock. It also supports large-scale community screening enabling convenient and

Rare disease Product universal early diagnosis. Second blood biomarkers allow for dynamic monitoring of disease progression and treatment

Atypical haemolytic uraemic sC5b-9 soluble terminal complement efficacy to guide precise intervention and combined monitoring can quantify pathological progression. Finally China has

the largest number of AD patients in the world (over 11 million patients aged 60 and above) with higher risks in rural areas

syndrome aHUS complex assay kit (magnetic particle based and among women. This technology can effectively address the challenges of China's aging population and optimize the

chemiluminescent immunoassay) public health prevention and control system. It provides a core tool for building a full-chain system of "screening-diagnosis-

treatment-prevention" for China's aging society and is of strategic significance for reversing disease progression and

alleviating public health pressure.In 2024 China's State Council issued the "Several Measures on Accelerating the Improvement of the Fertility Support Policy

Attention to chronic disease management and prevention System and Promoting the Construction of a Fertility-Friendly Society" which would implement in depth the Maternal and

With the increasing aging of population in China chronic diseases have become a major health threat. Under the value-based Infant Safety Promotion Action Plan and the Birth Defects Prevention and Treatment Capacity Enhancement Program. Human

healthcare framework to address this dilemma and further optimize chronic disease diagnosis and treatment pathways parvovirus B19 a pathogen capable of maternal-fetal transmission may compromise fetal development. In alignment with

we have launched appropriate and precise testing technologies through the innovation and application of cutting-edge national policies the Company has accelerated the development of human parvovirus B19 antibody detection solutions and

technologies in laboratory medicine which provides a new direction for chronic disease management guided by value- enhanced its comprehensive and high-quality TORCH screening panels. As of the end of the reporting period the Human

based healthcare and helps optimize the full lifecycle management of chronic diseases and clinical diagnosis and treatment Parvovirus B19 IgG Antibody Test Kit (magnetic particle based chemiluminescent immunoassay) had obtained the registration

pathways. test report and entered the clinical registration phase.

41 42Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

Facilitating the improvement of global public health services centralized and decentralized testing solutions the Company assisted medical institutions at different levels in enhancing their

Respiratory tract infections pose a long-term challenge to global public health. Their high transmissibility pathogen diversity testing capabilities. The specific activities undertaken are as follows.and symptom similarity place enormous pressure on clinical diagnosis treatment and disease prevention and control.As a pioneer in the global in vitro diagnostics field we deeply understand that diagnostic products are not only medical

Incorporating *Incorporate product planning for centralized terminals and primary healthcare settings into the

tools but also an important component of the public health defense system. In 2025 we conducted R&D of a series of healthcare annual R&D roadmap with a focus on supporting regional laboratory capacity building and the

testing products aimed at improving public health services and combating infectious diseases. These included respiratory accessibility development of the tiered diagnosis and treatment system.multiplex testing products that detect pathogens such as influenza A influenza B respiratory syncytial virus adenovirus and goals into *At the new project initiation stage concurrently assess equipment deployment conditions staffing

Mycoplasma pneumoniae. The goal is to accurately identify pathogens through a single sampling and testing especially for R&D strategy levels operational costs and long-term maintenance requirements and treat accessibility and

vulnerable groups such as infants young children and the elderly. This provides comprehensive etiological evidence to guide affordability as key decision dimensions.precise medication thereby curbing the spread of antibiotic resistance at the source reducing the burden on the medical *Establish a cross-departmental collaboration mechanism uniting marketing after-sales clinical

system and safeguarding public health. support and supply chain teams to incorporate end-user feedback and public health needs into

product planning inputs.Facilitating early screening early diagnosis and personalized diagnosis and treatment of cancer *Embed energy efficiency durability and life-cycle cost management requirements into the R&D

Guided by China's policy of early diagnosis and treatment the Company actively advances the development of early screening evaluation system to promote the economic viability and sustainability of products over long-term

and diagnostic products for cancer aiming to promote its early screening early diagnosis and early treatment and to reduce operation.cancer incidence and mortality rates. Expanding (I) Product R&D planning for centralized terminals

healthcare The Company is developing two new products for medium-throughput centralized testing terminal

DNA methylation detection as a rapidly developing molecular detection technology for cancer in recent years has shown service scenarios including a medium-speed biochemistry analyzer and an integrated sample processing

promising application prospects in early cancer risk assessment and auxiliary diagnosis. It features non-invasive or minimally coverage system both soon to be launched:

invasive sampling and the ability to capture potential early signals making it suitable for risk assessment and clinical through *Both products are designed to enhance the testing capabilities of regional laboratories optimize

decision support in specific populations. In addition DNA methylation biomarkers are being explored for disease progression innovative manpower allocation and improve operational efficiency meeting centralized testing needs.assessment and prognostic analysis in some studies and specific application scenarios. design and *The system architecture emphasizes modular design and scalability enabling medical institutions

platform- to gradually configure equipment based on testing volume thereby reducing the pressure of one-

The Company has achieved breakthrough progress in the field of methylation-based early cancer screening. Based on based R&D time investment.methylation-specific PCR technology the Company has developed single-cancer screening or auxiliary detection products for *By integrating sample pre-processing automated transmission and information system integration

multiple high-incidence cancers covering application scenarios such as colorectal cancer and cervical cancer. These products functions manual operations are reduced and process stability is improved.*During the design phase attention is also given to deployment space power conditions and

are used to detect the methylation of specific genes in the population using various sample types including fecal samples environmental adaptability to enhance applicability across medical institutions in different regions.human peripheral blood plasma and cervical exfoliated cells assisting clinicians in disease diagnosis. Regarding methylation (II) Optimizing product design to improve usability

instruments the R&D of methylation instruments had been completed by the end of the reporting period facilitating early *Continuously improve the user interface and interaction logic to reduce training costs;

screening and early diagnosis of related diseases. *Strengthen intelligent reminders operation monitoring and remote support capabilities to improve

the transparency of equipment operation;

Malignancies have become one of the major disease burdens worldwide. The traditional "trial-and-error" approach of *Introduce multi-scenario use validation during the R&D phase to ensure product suitability for

chemotherapy not only delays patient treatment but also results in enormous waste of medical resources and patient different medical environments.suffering. As a "navigator" for precision medicine the core value of companion diagnostics lies in finding the right drug for the (III) Adopting a modular and standardized design to improve affordability

right patient at the right time. To this end the Company has introduced a digital PCR platform through strategic cooperation *Promote platform-based architecture and standardization of core components to control R&D and

which with its high sensitivity and excellent quantification capabilities provides more precise medication guidance for cancer manufacturing costs;

patients. During the reporting period relying on this technology platform the Company achieved key breakthroughs in two *Optimize part and component selection and process solutions to enhance supply chain stability;

*Adopt a durable design and maintenance-friendly structure to reduce life-cycle operation and

major cancers breast cancer and non-small cell lung cancer. maintenance costs.(IV) Supporting applications in primary and resource-limited regions

By dynamically monitoring drug-resistant mutations using the digital PCR platform treatment regimens can be adjusted in *Optimize installation and deployment methods to improve operational reliability in complex

a timely manner supporting personalized diagnosis and treatment and avoiding the huge medical expenditures incurred environments;

by ineffective targeted therapies as well as the radiation exposure and resource consumption from unnecessary imaging *Promote low-energy-consumption design to reduce operational burden;

examinations. This approach not only respects life but also maximizes the use of limited medical resources. *Fully cover scenarios of continuous operation and simplified maintenance during the validation

phase.Promoting access to quality medical resources (V) Using digital tools to empower laboratory efficiency

Adhering to the original intention of "making medical examinations more affordable for the public" the Company is *Use data analysis and operational monitoring functions to help laboratories shorten testing

continuously promoting accessibility to high-quality medical resources. In 2025 the Company's Instrument R&D Department turnaround time;

consistently prioritized enhancing accessibility to medical services improving clinical user experience and reducing total cost *Strengthen system interconnection capabilities to support laboratory informatization;

*Upgrade software to extend equipment life-cycle.of ownership as key directions of R&D governance. The concept of accessible and affordable healthcare was systematically

embedded in the product planning design development and validation phases. Through the coordinated development of

43 44Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

By systematically embedding the concept of healthcare accessibility into R&D governance and product development practices

the Company made positive progress in promoting healthcare coverage in 2025 which also reflects its commitment to social

Green production: Promoting efficient and low-carbon collaborative manufacturing

responsibility.*Material and process optimization to reduce production energy consumption: Relying on lightweight and

integrated front-end design the demand for raw materials and processing complexity were directly reduced.In the future the Company's R&D department will continue to promote technological innovation and process optimization

The simplified structure reduced material consumption and energy input during production while the

and remain committed to creating more high-quality and cost-effective medical devices further improving the accessibility of

streamlined assembly process also reduced labor hours and energy consumption thus achieving low-carbon

medical resources and contributing to the sustainable development of the global medical industry.manufacturing.Green R&D

*Supply chain collaboration for full-chain carbon reduction: The reduction in the total number of parts enabled

The Company's instrument R&D team continues to delve into the field of sustainable development integrating the green

upstream suppliers to consume raw materials more precisely reducing the production and waste risks of excess

sustainability principle into every detail of products' life-cycle management. From the design iteration of core components

materials; the product's overall weight reduction and structural optimization further lowered fuel consumption

to the optimization of production and assembly and then to subsequent use and resource recycling the team consistently

and carbon emissions during logistics and transportation promoting the green transformation of the full supply

leverages technological innovation to minimize environmental impact. By upholding and upgrading its green development

chain.concept the Company provides customers with efficient and environmentally friendly solutions while continuously

strengthening its sense of responsibility in the field of green medical equipment.*Precise consumable management and control to reduce waste volume: For SATLARS mini-T8's sample

processing unit the reduction in the number of standard parts such as screws used (reduced by approximately

15%) and the optimization in part structures significantly lowered the amount of processing consumables used

during production and reduced manufacturing waste; the standardized and intensive design also reduced

resource input for subsequent consumable replacement and maintenance forming a full-cycle green material

The Company's SATLARS mini-T8 Laboratory Automation System management system.embodies green concepts and life-cycle design Green packaging: Practicing sustainable logistics

*Continued application of environmentally friendly materials: In this new product we still actively promoted the

Green design: Advancing lightweight and intensive design replacement of plastics and wood with paper and used recyclable paper-based substrates and environmentally

*Structural lightweighting to lower both material and energy consumption: For SATLARS mini-T8's cold friendly cushioning materials significantly reducing dependence on traditional plastics and wood and lowering

storage unit we optimized its structural design through simulation analysis while maintaining the resource consumption and environmental pollution.structural advantages of SATLARS T8. Under the premise that part strength requirements were met the

weight was reduced by approximately 36% effectively reducing material usage and directly lowering *Lightweight packaging design: By optimizing the packaging structure and using high-strength thin materials

carbon emissions during subsequent transportation thereby extending the green value contributed at the and multi-module combination solutions the total volume and weight of the packaging were effectively

design phase. reduced which not only saved storage and transportation space but also directly reduced energy consumption

and carbon emissions during logistics.*Storage efficiency upgrades to optimize resource utilization: Through systematic design upgrades

SATLARS mini-T8's cold storage unit achieved a simultaneous improvement in storage density per unit *Strict adherence to international standards: All packaging materials strictly complied with international

volume and overall energy efficiency ratio truly realizing the green design goal of "create higher value environmental regulations and recycling standards ensuring they are recyclable and biodegradable. We

with fewer resources" and indirectly reducing energy consumption during use. are committed to providing customers with green packaging solutions that meet global environmental

requirements supporting the development of a sustainable supply chain.*Part integration and simplification to reduce resource consumption at the source: A comprehensive

structural integration and simplification was carried out on SATLARS mini-T8's sample processing

unit. By optimizing wiring simplifying transmission and support structures and integrating functional

components the number of part types was reduced by approximately 14% and the number of parts

by approximately 11%. This simplified material management and resource consumption at the source

facilitated subsequent maintenance and upgrades and reduced resource waste caused by product

replacement.*Snap-fit connection optimization to reduce consumable usage: The innovative snap-fit fixing solution

replaced some traditional connection methods which not only simplified the assembly process and

improved efficiency but also significantly reduced the number of small consumables such as screws used

facilitating subsequent maintenance and recycling and lowering resource consumption during use and

disposal.

45 46Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

Intellectual property protection >

Snibe strictly abides by and implements national and regional laws regulations and standards such as the "Patent Law of

the People's Republic of China" and "Trademark Law of the People's Republic of China" formulates the "Intellectual Property

Management Procedure" "Patent Management Procedure" "Trademark Management Procedure" "Works Management

Procedure" and other management documents and continuously improves the construction of intellectual property Supply Chain Management

management system.We pay attention to intellectual property protection. With a dedicated team of professionals and a mature management

system we integrate intellectual property creation and protection into our R&D and innovation system to provide strong

support and guarantee for our product R&D and technological innovation. Internally the Intellectual Property Department

adopts early warning for project research project initiation R&D and product launch to manage risks throughout the

development process and protect our technological innovations. Externally investment financing and technological A stable safe and quality supply chain provides an important

cooperation are conducted with an early warning mechanism to reduce potential risks. At the same time we actively organize guarantee for us to offer high-quality products all the time.training sessions to help employees understand intellectual property compliance and obligations and strengthen their Guided by "The Bidding Law of the People's Republic of China"

awareness and professional competence in intellectual property protection. and other relevant laws and regulations Snibe has developed a

sound supplier management system. In addition to the quality

With the outstanding performance in the creation application protection and management of intellectual property rights

Snibe won the title of "National Intellectual Property Demonstration Enterprise" in 2023 and won the title of "National of products and services the Company also pays attention

High-tech Enterprise" in 2024 fully demonstrating Snibe' exemplary and leading role in the independent control of core to the management of suppliers in terms of business ethics

technologies and the strategic deployment of intellectual property rights. environmental awareness occupational health and safety and

continues to convey the concept of sustainable development to

By the end of 2025 the Company has had 743 patents filed 426 valid patents granted (including 197 valid invention patents) suppliers to ensure the quality and sustainability of suppliers.

742 valid trademarks registered and 60 software copyrights.

Cumulative number of Number of valid patents Cumulative number of valid Cumulative number of

patents filed granted trademarks registered software copyrights

Supplier management >

743 426 742 60 Management systems such as the "Bidding Management System" the "Control Procedure for Procurement" the "Anti-Bribery

Including valid invention Control Procedure for Procurement Transactions" and the "Supplier HSF Management Regulations" have been formulated

patents to systematically supervise and manage supplier development and admission ordering performance evaluation re-

evaluation qualification management and supplier elimination forming closed-loop management to ensure the fair and

197 effective operation of the procurement supply chain.

We continuously optimize supplier management and in accordance with relevant system requirements achieve

comprehensive and high-standard management of our major business partners. We conduct anti-commercial bribery

investigations and annual reviews for our major business partners with a coverage rate of 100% to prevent compliance

risks at the source. Mandatory anti-bribery training sessions with competency assessments are organized for suppliers

accompanied by the signing of "Letter of Commitment for Anti-Commercial Bribery" or "Anti-commercial Bribery Agreement"

internalizing integrity-based cooperation as a common principle for both parties. We have completed the signing

of "Environmental and Occupational Health and Safety Policy Notice" across our partner network and the signing of

"Supply Chain Information Security Agreement" with major suppliers establishing risk control measures for environment

occupational health and safety and information security. In addition this year we have newly formulated the "Supplier On-

site Audit Management Regulations" which not only standardizes the audit management of external suppliers but also

proactively urges and guides suppliers to improve their management in areas such as quality management anti-commercial

bribery environment occupational health and safety and information security.

47 48Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

In accordance with the "Control Procedure for Procurement" the Company conducts annual requalification audits for both Sustainable supply chain management >

probationary and approved suppliers. Suppliers not up to standards are included on the "List of Unqualified Suppliers"

based on the type of materials they supply. Rectification and guidance support are available to urge and help suppliers To ensure the quality and supply safety of important materials Snibe divides suppliers into three categories of A B and C

improve their management processes and measures thus ensuring the stability and improvement of the supplier quality by the importance of supplied materials management to the product. Suppliers are reviewed and evaluated with category-

and eliminating unqualified suppliers. Meanwhile by establishing supplier management files we regularly record suppliers' specific indicators and standards based on the types of their materials and the nature of business. Category A suppliers are

qualification changes cooperation updates and performance. Based on these records we periodically review and audit required to establish a sound quality management system and sign a quality assurance agreement.suppliers monitoring and strictly assessing whether to retain their cooperation eligibility.After years of technology accumulation we have established a well-developed supply chain risk management system. On

In 2025 the Company added 50 new suppliers and removed 4 suppliers due to quality issues. the one hand we enhance the safety inventory management of core components and include more alternative suppliers.On the other hand we join hands with domestic manufacturers to develop and apply for major special projects of Shenzhen

to promote the R&D and substitution of domestic core components. For key components Snibe and suppliers need to work

closely on all-round material recognition to fully guarantee the safety of materials. For some key materials Snibe has

formulated Plan B to deal with sudden risks in the supply chain. For materials with a large amount of consumption we usually

Supplier admission Supplier re-evaluation Supplier elimination purchase them from two or three suppliers at the same time to avoid the situation that the production of products is affected

by the shortage of materials. Amidst the push to replace foreign goods with domestic alternatives in the manufacturing

· Preliminary investigation · Supplier classification · Supplier monitoring industry Snibe has opted for more domestic materials after verification consolidating supply chain security. Furthermore the

· Production and R&D capabilities management · Eliminating abnormal strong R&D team for key reagent materials serves as a solid backbone to guarantee the stable supply of raw materials for our

· Quality assurance ability · Supplier qualification suppliers reagent products. At present most of the Company's key reagent materials have achieved self-sufficiency effectively reducing

· Intellectual Property Rights management the risk of limited raw material procurement channels and ensuring the stability of the key reagent material supply.· Environmental health and safety · Risk management of supplier

· Social responsibility and ethical · Organizational Structure As for supply chain operation and inventory management the annual demand forecasting is updated on a rolling basis (2 + 3

standards · Price level short-term + long-term) so that both suppliers and Snibe can maintain dynamic safety inventory for quick response to flexible

· Sample validation · Production Capacity demand. At the same time based on production needs and procurement plans we collaborate with suppliers to discuss and

· Enquiry and quotation · Quality assurance ability formulate reasonable inventory quantities and delivery schedules and continuously update these to ensure smooth supply

· On-site certification and review · Environmental risk chain operations and improve delivery flexibility and response speed.· Anti-commercial Bribery assessment

Investigation · Anti-commercial Bribery When selecting supply resources we prioritize suppliers that are geographically close to us and have a relatively complete

Investigation system to ensure flexible delivery and timely effective communication and audit in quality control as well as in-depth

communication and careful evaluation during R&D cooperation to guarantee stable supply after delivery.Supplier communication >

Technical exchange is an important measure to ensure product quality. Whenever quality anomalies are identified during

regular supplier performance reviews we immediately coordinate with relevant departments and suppliers to jointly discuss By the end of 2025 the proportion of suppliers in and the proportion of suppliers in Hong Kong

solutions. A regular communication and feedback mechanism has been established around the monthly incoming material the Chinese mainland was Macao Taiwan and overseas was

pass rate and on-time delivery rate. For suppliers not up to standards or ranking low in performance we proactively organize

special meetings to invite them to review their quality performance in person. Through in-depth discussions on quality 96.3% 3.7%

standards we establish mutually agreed control standards and on this basis formulate effective corrective and preventive

actions as well as quality improvement measures thereby further enhancing material quality levels. In 2025 we organized

more than 330 online and offline meetings with suppliers.In the on-site audit stage before the new supplier was admitted the Procurement Department would jointly conduct on-

site visits and exchanges with the personnel of relevant upstream and downstream departments such as R&D and quality

inspection. Based on the annual evaluation results of suppliers and the problems found in their daily management process

we would formulate an annual visit plan or arrange an unannounced audit timely discuss with suppliers about the quality

and sustainable development issues found in the audit and discontinue the supply from suppliers to be rectified to mitigate

supply risk. In 2025 we conducted a total of 26 pre-admission and annual on-site audits.

49 50Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

As required by the "Regulations on the Management of Domestic Distributors" Snibe strictly abides by the "Anti-Unfair

Responsible Marketing Competition Law of the People's Republic of China" and the "Interim Provisions on Prohibition of Commercial Bribery". For brand building and market development we have formulated the "Management System for Domestic Academic Conferences"

to regulate the organization of academic conferences and academic promotion. An internal customer management platform

which covers five modules of customer management market management product management distributor management

and database has been developed to help marketing personnel master information on customer relations meeting

procedures product information and online distributor management. This is how we realize responsible marketing.Snibe has always put the rights and interests of users first.Through strong brand building and the domain-specific In overseas markets under the framework of the Company's ISO 13485 quality management system we follow the

expertise competency enhancement of the marketing and "Regulations on the Management of Overseas Distributors" implement the ISO 37001 anti-bribery management system

after-sales service personnel the Company unswervingly standard and require overseas distributors to conduct business as per local laws and regulations. To ensure global regulatory

compliance of post-market products the Company strictly abides by the regulatory requirements of various countries/

implements responsible marketing continuously elevates regions for medical devices and sets appropriate labels when selling products to ensure that the end users are fully aware

client service capabilities empowers customers and fosters of the product information. For example for distributors in the EU we adapt our products and business to the latest IVDR

industry exchanges and cooperation to expand the Company's and transitional provisions for example adding the information of EU importers and updating compliance declaration. To

leadership in the industry. safeguard the interests of distributors and end users we proactively communicate with customers and end-user hospitals

regarding products undergoing phase-out or discontinuation providing advance notification of discontinuation timelines to

establish transition periods for users while simultaneously offering optimized alternative solutions.Responsible marketing management > Responsible brand building >

Management systems such as "Control Procedure for Customer-Related Processes" "Regulations on the Management Brand control and supervision

of Domestic Distributors" "Regulations on the Management of Overseas Distributors" "Regulations on the Management During product marketing and promotion the Marketing Department submits the new products and promotional materials

of Publicity Materials" "Regulations on the Management of Intellectual Property Rights in Advertising and Exhibitions" (including the commissioned design of advertisements) to the Intellectual Property Department for review in strict accordance

"Regulations on the Management of Intellectual Property Rights in Market Sales" and "Anti-Bribery Control Procedure for with the requirements specified in the "Regulations on the Management of Intellectual Property Rights in Advertising and

Distributors' Sales Business" have been established to form a sound marketing management framework to ensure the Exhibitions" and the "Regulations on the Management of Intellectual Property Rights in Market Sales" so as to ensure

protection of customer rights and interests and improve customer satisfaction during the course of business. compliance with the Company's requirements for patent trademark and copyright protection. At the same time we require

that the content of promotional materials be truthful and scientific and must not contradict the content of product labels

In both domestic and overseas markets we adhere to the five principles of equality and mutual benefit integrity and legal and instructions. Exaggerated statements are prohibited and the use of text names images or other similar labels that may

compliance win-win result and long-term cooperation daily management with regular evaluation and zero tolerance for mislead users regarding the intended use safety or performance of products is forbidden. Furthermore all materials sent to

bribery to manage distributors. external parties must undergo strict internal approval.The Marketing Department is responsible for market supervision and risk control and prevention in the product release

and publicity process. The Company also closely monitors the behaviors that damage our brand building and clarifies the

Communication with customers responsible departments and measures to deal with violations against our intellectual property rights to maintain Snibe's

brand image.Brand building

In 2025 the Company launched several major instrument products including the ultra-high-speed fully-auto

chemiluminescence immunoassay analyzer MAGLUMI X10 the ultra-high-speed biochemistry analyzer Biossays C10 the

high-speed fully-auto electrolyte analyzer Biossays E6 Plus and the high-speed automated coagulation analyzer Hemolumi

H6. The successive launches of these products provide important opportunities for the Company's brand building. The

Company actively promotes brand building across all departments. We continue to carry out brand promotion through

Identification Determination Review of Implementation After-sales various channels and forms such as exhibitions academic conferences and official WeChat accounts to enhance the

of product of product product of bidding and feedback Company's industry influence.requirements requirements requirements contract/order

51 52Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

In terms of brand building in overseas markets the Overseas Sales Department and Overseas Marketing Department have

held academic exchanges such as Snibe Day to enhance the Company's international brand influence.Promotion of MAGLUMI X10 and Biossays C10

"Snibe Day" is jointly organized by the Company the International Federation of Clinical Chemistry and Laboratory Medicine

(IFCC) and globally renowned medical associations and laboratories. Focusing on current challenges future directions

In Mar. 2025 at the Annual Conference & EXPO China Congress for Diagnostics & Laboratory Medicine and key issues in medical laboratory immunoassays the event brings together renowned experts in international medical

(CCDLM) and the 22nd China International In Vitro Diagnostic Expo (CACLP) the Company exhibited laboratory science to share the latest clinical applications and research advances promoting the translation of research

and launched the fully-auto chemiluminescence immunoassay analyzer MAGLUMI X10 and the next- findings into clinical practice and vigorously facilitating knowledge sharing and cross-border cooperation in the field of in

generation biochemistry analyzer Biossays C10 for the first time in China. MAGLUMI X10 with its ultra-fast vitro diagnostics.immunoassay throughput of 1000 tests per hour MPC micro-precision sampling technology as well as

zero-contamination zero-pulsation and zero-degradation steady-state washing technology ensures In 2025 we successfully held more than 10 "Snibe Day" brand events which were launched in China and many countries

high efficiency accuracy and stability of immunoassays. overseas. The "Snibe Day" events transcend one-way communication. With an open attitude the Company invited key global

partners to come together experience the smart production line and witness how precision instruments were born; they

also visited hospitals to see how the equipment drove efficient diagnosis and treatment. When manufacturing strength meets

clinical needs we jointly create a closed loop of trust. This is not just a showcase but a commitment: Snibe ensures that

every technology withstands the test of real-world application.International Symposium on Laboratory Medicine

On Aug. 24 2025 the International Symposium on Laboratory Medicine was held at the headquarters

Promotion of T8 total laboratory automation coagulation analyzer and of Snibe in Shenzhen. The conference was jointly organized by the International Federation of Clinical

electrolyte analyzer Chemistry and Laboratory Medicine (IFCC) and Snibe and invited 14 lecturers and over 300 participants.The conference was honored to have the attendance of Professor Tomris Ozben (President of the IFCC)

In Sep. 2025 the 14th National Conference of Clinical Laboratory Management (NCCLab) organized by Professor Khosrow Adeli and Maurizio Ferrari (former Presidents of the IFCC) and Professor Mario Plebani

the Chinese Hospital Association was held in Chengdu. As an important academic exchange platform (President of the European Federation of Clinical Chemistry and Laboratory Medicine [EFLM]).in the field of clinical laboratory management in China the Company made a stunning appearance at

the conference with a series of high-quality laboratory solutions and disease diagnosis and treatment

solutions including SATLARS T8 the high-speed fully-auto electrolyte analyzer Biossays E6 Plus and the

high-speed automated coagulation analyzer Hemolumi H6.

53 54Product Quality Focusing on R&D Supply Chain Responsible Customer Service Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality and Safety and Innovation Management Marketing Quality

Customer Service Quality

Enhancing Snibe's brand influence through participation in international

exhibitions

In 2025 the Company participated in more than 140 international exhibitions worldwide including

important industry platforms such as Medlab Middle East EUROMEDLAB ADLM and Medica. On these

stages we systematically showcased cutting-edge laboratory technologies and innovative solutions and With the core strategic concept of "customer-centric market-

collaborated closely with global partners to address real-world challenges in the diagnostics field and oriented" Snibe keeps optimizing customer service solutions

actively shape the future direction of medical diagnostics. in all aspects by understanding customer needs timely

responding to customer complaints providing professional and

accurate services and investigating customer satisfaction so

as to provide customers with safe reassuring and innovative

products and services.Customer service management and capabilities >

We practice the "service +" concept to continuously improve customer service experience and provide carefree services

Responsible marketing training > for customers. We have formulated and implemented management systems such as the "Control Procedure for Servicing

Activities" to standardize the customer consultation and complaint handling process. Through systematic training and

The Company highly values the professional and academic capabilities of its marketing team. It has established a systematic professional guidance we continuously strengthen the team's professional ability and service awareness and optimize the

regular and effective training system that closely aligns with business strategies and effectively empowers the marketing quality of customer service.frontline and support teams.By 2025 the Company has built 190 service stations and upgraded on-site services in various regions across China ensuring

In 2025 the domestic marketing center organized 54 regular training sessions covering areas such as promotion strategies customer response in 1–2 hours. To help technical engineers in different regions solve customer problems in a systematic way

case sharing knowledge training (luminescence instrumentation biochemistry coagulation) and policies. Details are as we have developed the remote service system Snibe Link on our own to ensure a comprehensive and professional customer

follows: service. We are committed to providing customer-centric rapid-response and professional services to create worry-free and

value-added experiences.The domestic marketing center has established a weekly fixed-time joint training mechanism for the three teams (product

managers sales personnel and technical service engineers) to ensure information synchronization. The training content In overseas markets Snibe implemented regional management with independent marketing after-sales market and

includes: (1) product and technical knowledge with in-depth training on clinical applications report interpretation and business for each region. Product sales and after-sales personnel are better connected to improve the regional product and

promotional advantages across six major areas including bone metabolism hypertension and tumor biomarkers; (2) service performance. More foreign technical service personnel were recruited to ensure timely response to the urgent needs

interpretation of market dynamics and policies with timely launch of courses on the rationale for test panels; (3) regular of distributors and end customers. As we expand our product lines the number of overseas channels is also expanding

sharing of excellent promotion cases as well as distributor cultivation and benchmark hospital construction experience; in terms of both breadth and depth to bring quality products and services to more customers across the world. In major

(4) regular special strategy training for regional directors deputy directors and other management personnel to unify the countries and markets the Company strengthens localization through the establishment of overseas subsidiaries. Up to

promotion consensus of regional leaders and ensure the accurate implementation of strategies. now we have set up overseas subsidiaries in 16 countries. By recruiting local employees and applying for product circulation

licenses overseas subsidiaries boost localized operations for more meticulous and comprehensive market coverage and

To ensure training effectiveness the domestic marketing center adopts the "Learn-Test-Evaluate" approach. Post-training premium service for end customers.tests are released via an online platform to enable immediate assessment of learning outcomes. By analyzing the distribution

of test scores the center continuously refines training content and formats to ensure high relevance to actual work.

55 56Product Quality Focusing on R&D Supply Chain Responsible Customer Service

and Safety and Innovation Management Marketing Quality

Customer satisfaction >

We truly adhere to the principle of delivering timely efficient dedicated professional thorough and quality service to

customers. In case of any product problems customers can get in touch with us through the "400" hotline official mail

and "External Information Feedback Form" on the official website. In addition our technical service personnel strictly

follow Snibe's "Control Procedure for Feedback and Complaint Handling" for closed-loop management through regular

maintenance & customer visit and timely communication with customers. In 2025 100% of the complaints received have been

handled with a customer satisfaction rate of 100%. 03

We regularly conduct customer satisfaction surveys to understand the opinions and suggestions of customers on the

Company's products and services. In 2025 the domestic and foreign customer satisfaction reached more than 98%.Improving customer service capabilities > PROMOTING GREEN

We maintain proactive two-way communication through a customer-centric approach to deliver sustained customer OPERATION

empowerment. ISO 15189 is an internationally recognized standard for quality and competence management in medical

laboratories. To help the medical laboratory departments establish a standardized quality management system and improve Major issues

the accuracy and mutual recognition of test results we have provided ISO 15189 full-process support. This year we continued · Addressing climate change

to provide ISO 15189 training and guidance to end customers in various regions and built a combined online and offline · Emissions and waste management

platform for specialized training and exchanges to fully empower customers to apply for accreditation. During the daily · Environmental management

service process we discussed with laboratory teachers the problems and questions encountered in the validation analysis · Resource management

to enhance their understanding of immunoassay product applications help them master product applications and analysis · Energy management

validation methods and improve laboratory quality management.We attach great importance to the construction and training of technical service engineers. In 2025 we organized training

for domestic technical service engineers and provided on-site and online training for technical service engineers of overseas Alignment with Sustainable Development Goals (SDGs)

agents to comprehensively enhance their professional service capabilities. At the same time through the "Snibe Forum"

online platform we delivered knowledge to technical service engineers of our agents to promote their understanding of the

latest product-related information. On this platform product-related information is constantly updated and those engineers

can learn to operate the product quickly.Snibe deeply practices the concept of sustainable development

strictly aligns with environmental protection conservation and safety

production management standards and continuously strengthens

the construction of its environmental and occupational health and

safety management system. We integrate the concepts of green

operation and safe production into all aspects of daily operations.While ensuring employee safety and health we strive to create an

efficient and environmentally friendly operation model promoting

the deep integration of green development and safe operation.

57Environmental and Occupational Health and Safety Management Addressing Climate Change Green Operation Environmental and Occupational Health and Safety Management Addressing Climate Change Green Operation

Environmental and occupational health and safety management initiatives >

Environmental and Occupational

Health and Safety Management Area Initiatives

Environmental Waste management: Strictly implement the "Wastewater Emissions and Noise Management

management System" and the "Environmental Protection and Harmless Treatment System" and implement

classified storage compliant disposal and full-process monitoring of various wastes

generated from production and daily activities ensuring full compliance with environmental

regulations and effectively safeguarding the environment.Employee safety and environmental protection constitute the Resource and energy management: Continuously implement the "Resource and Energy

cornerstone of our continuous and stable development. Snibe Consumption Control Management System" to regulate employees' practices in conserving

has always adhered to the policy of "Environment protection water and electricity. Post water and energy conservation signs to improve employees'

health and safety compliance with regulations and sustainable awareness of energy saving and emission reduction. Implement quota control for office

development" to continuously strengthen the Company's overall supplies. Integrate green design concepts into product design and production processes and

optimize the use of raw and auxiliary materials to reduce resource waste at the source.safety and environmental protection construction. Snibe maintains

strict adherence to laws and regulations like the "Labor Law of the Hazardous waste management: Establish the "Hazardous Waste Management System" to

People's Republic of China" the "Environmental Protection Law of clarify the requirements for identification classification labeling storage transfer and

the People's Republic of China" the "Safety Production Law of the disposal of hazardous waste. Maintain hazardous waste management records implement

People's Republic of China" the "Fire Control Law of the People's the declaration and transfer manifest system and eliminate environmental risks.Republic of China" and the "Law of the People's Republic of China

Health Domestic water management: Establish the "Management System of Drinking Water for on Prevention and Control of Occupational Diseases" and has

management Domestic Use" to clarify water quality testing standards for domestic drinking water tanks

developed relevant supporting management systems according limits for key indicators and water quality testing standards for direct drinking water.to those laws and regulations and internal management needs to Commission external agencies to conduct water quality testing biannually entrust third-

continuously improve environmental and occupational health and party agencies to inspect water fountains routinely and clean the internal tanks of water

safety management. dispensers quarterly ensuring that the Company's domestic drinking water fully complies

with the national standards for drinking water quality.In 2025 the Company invested 4.58 million yuan in environment Occupational health management: Establish the "Management System for the Prevention

and occupational health and safety. and Control of Occupational Diseases". Sign the "Job-Specific Occupational Disease Hazards

Notice" with employees in high-risk positions which clearly outlines job-related hazards.Provide compliant and necessary personal protective equipment to all employees in high-

risk positions. Conduct annual monitoring of occupational hazard factors. Organize pre-

employment in-service and post-employment occupational health examinations for

employees in high-risk positions. Maintain employee occupational health records to timely

identify and address occupational health issues.Canteen safety management: Establish the "Canteen Management System" to strengthen

canteen hygiene management. All the canteen staff are on duty with certificates. Conduct

Environmental and occupational health and safety management policy and objectives > regular inspections of food quality and hygiene management. Develop record forms for key

steps in the meal preparation process to ensure full traceability and risk control of canteen

Policy: Environment protection health and safety compliance with regulations and sustainable development. management. Formulate a special emergency response plan for food safety clarifying

Objectives: emergency response procedures responsibilities and handling processes for sudden

(1) Zero fire incidents incidents such as food poisoning.

(2) Zero chemical leaks and explosions

(3) Zero work-related fatalities or serious injuries Work-related injury management: Strictly implement the "Work-related Injury Management

(4) Zero occupational diseases System" to ensure proper reporting investigation identification and medical treatment

procedures for work-related injuries safeguarding employees' legitimate rights and

interests.

59 60Environmental and Occupational Health and Safety Management Addressing Climate Change Green Operation Environmental and Occupational Health and Safety Management Addressing Climate Change Green Operation

Area Initiatives

Addressing Climate Change

Emergency Emergency procedure management: Establish the "Emergency Preparedness and Response

management Control Procedures" to define the organization process evaluation criteria and improvement

mechanisms for emergency drills and standardize the drill record template promoting the

standardization and traceability of emergency management. Focusing on major risks such

as fire and hazardous chemical leaks regularly organize comprehensive emergency drills

involving multiple departments to test the effectiveness of emergency plans and improve

employees' capabilities in emergency evacuation initial response and coordinated action. Snibe recognizes that the physical impacts of global climate

change and mitigation actions may pose significant risks or

Emergency resource management: Strictly implement the requirements for medicine create opportunities for our business. During the reporting

allocation inspection replacement and documentation as specified in the "First Aid Kit and period we identified relevant entity risks transformation risks and

Medicine Management System" to ensure that first aid medicines and equipment in all areas opportunities based on the business development and operation

are always in good condition and ready for use. Establish a first-aider team with basic first-

aid knowledge and skills. of the Company and formulated corresponding countermeasures.Safety Equipment safety management: Establish various safety operation procedures and safety Type Influencing factors Specific impact Countermeasures

Management management systems strictly implement pre-employment safety training and ensure that

special equipment operators/special operation personnel hold valid certificates. Regularly Entity risk Heavy rains Snibe operates in a coastal city We actively monitor climate trends and have

inspect and maintain production equipment electrical wiring and safety protection facilities typhoons and where increased frequency or developed an extreme weather emergency

to ensure the safe and stable operation of equipment and facilities. other extreme intensity of extreme weather events response plan tailored to local conditions.weather occur like heavy rains and typhoons may We pay close attention to weather warning

Hazardous operations safety management: Establish the "Hazardous Operations frequently or disrupt facility power supply leading information and implement the following

Management System" to improve the approval and management requirements for high- increase in to water/power outages or damage preventive measures prior to forecasted

risk operations such as hot work high-place work and confined space work. Strengthen intensity to warehouses and equipment. Such extreme events: conduct safety inspections

pre-operation risk identification safety briefings and implementation of protective risks threaten both property security clear drainage systems repair roofs

measures and assign dedicated personnel for on-site supervision to ensure that the entire and our operational stability. reinforce perimeter walls install water

process of hazardous operations is under safe control. barriers strengthen ventilation enhance

circuit leakage protection improve

Hazardous chemicals safety management: Strictly implement relevant hazardous firefighting capacity etc.goods management systems fully standardizing the management requirements for the

classification storage labeling use and waste disposal of hazardous chemicals. Assign Transformational Energy prices At present Snibe's main energy The Company has proactively implemented

dedicated personnel to manage and document chemicals inventories deploy firefighting risk rise as countries consumption relies on externally energy management strategies including

facilities and emergency response equipment and regularly inspect their effectiveness. respond to climate sourced electricity. Environmental technology upgrades source-level energy

change protection regulations are becoming consumption controls intensified energy

Fire safety management: Strictly abide by relevant fire safety regulations and systems. increasingly stringent with national conservation and emission reduction

Establish the "Fire Equipment and Facilities Management System" to clarify the organization and local governments rolling out propaganda etc. to reduce energy

and implementation of daily fire safety management. Equip all areas with appropriate fire policies to restrict corporate carbon consumption and carbon emissions.equipment emergency exit indicator lights etc. as required. Regularly conduct inspections emissions. Rising fossil fuel prices

and maintenance of fire equipment and organize company-wide fire drills and fire safety have also driven up energy-related

training. operational costs.Investors are Snibe recognizes that domestic and The Company has actively responded to

increasingly international investors prioritize investors' concerns and voluntarily initiated

focused on transparency in greenhouse gas climate risk identification greenhouse

corporate climate (GHG) emissions and emission gas emission management and other

action reduction targets. Failure to actively programs for disclosure. Moving forward

manage GHG emissions could lead the Company will further develop GHG

to ESG rating downgrade negative reduction objectives in line with the needs

publicity reputational damage of enterprise development.and ultimately restricted financing

channels and higher capital costs.

61 62Environmental and Occupational Health and Safety Management Addressing Climate Change Green Operation Environmental and Occupational Health and Safety Management Addressing Climate Change Green Operation

The energy usage of Snibe in 2025 is detailed as follows:

Type Influencing factors Specific impact Countermeasures

Opportunity Climate change Global climate and environmental Snibe is closely tracking diagnostic

leads to increased shifts particularly rising demands linked to climate-sensitive

demand for new temperatures are increasing the diseases and proactively advancing R&D

products likelihood of infectious disease of targeted testing products. Purchased electricity Natural gas Gasoline Diesel

outbreaks and respiratory health

risks which creates new product 27281049.87 51719 25.16 9.89

opportunities for IVD companies. kWh cubic meters tons tons

Climate change Reduced energy and resource Through energy conservation and

policies promote consumption lowers both corporate emission reduction initiatives including

technological emissions and operational costs. By technological transformation and

upgrading of adopting more efficient production equipment upgrading the Company Snibe's carbon emission reduction target: To maintain a stable carbon emission intensity before the completion of Phase V of

enterprises and technologies the Company can continuously improves energy the R&D and production base and to achieve a steady decline in carbon emission intensity after the completion of Phase V

increase benefits increase production capacity and and resource utilization efficiency and the normal operation of the R&D and production base. The main basis is that Phase IV of the R&D and production base will

revenue while enhancing resource achieving cost reduction and efficiency be completed in 2025 and the base will then be put into use. With expanding business operations electricity consumption is

efficiency. enhancement. expected to rise significantly year-on-year creating substantial short-term pressure on carbon intensity metrics.The Company's greenhouse gas emissions predominantly stemmed from the utilization and consumption of electricity

natural gas gasoline and diesel in its production and operations direct emissions resulting from the escape of refrigerants

and indirect emissions resulting from the consumption of purchased electricity. During the reporting period we commissioned

SGS an international authoritative certification body to carry out a comprehensive and detailed greenhouse gas verification

audit and obtained the ISO 14064-1:2018 Greenhouse Gas Verification Statement Certificate issued by SGS.In 2025 the total carbon dioxide emissions (Scope 1 and Scope 2) resulting from the Company's operations amounted to Green Operation

17071.48 tons of CO2 equivalent. Among these direct emissions (Scope 1) accounted for 2589.96 tons of CO2 equivalent

while indirect emissions (Scope 2) stood at 14481.52 tons of CO2 equivalent. The carbon emission intensity was 0.0373tons of

CO2 equivalent per 10000 yuan * .Rigorously adhering to the "Water Pollution Prevention and Control Law of

the People's Republic of China" the "Law of the People's Republic of China on

Total emissions of Scope 1

Direct emissions (Scope 1) Direct emissions (Scope 2) and Scope 2 Carbon emission intensity the Prevention and Control of Atmospheric Pollution" the "Law of the People's

2589.96 14481.52 17071.48 0.0373 Republic of China on the Prevention and Control of Environment Pollution Caused by Solid Wastes" the "Regulations on the Administration of Medical Wastes" and

tons of CO2 tons of CO2 tons of CO2 tons of CO2

equivalent equivalent equivalent equivalent/10000 RMB other laws and regulations the Company has formulated management systems

such as the "Control Procedure for Environmental Issues" the "Resource and

Energy Consumption Control Management System" the "Wastewater Emissions

and Noise Management System" and the "Hazardous Waste Management

System" so as to effectively utilize resources and energy and strictly oversee the

disposal process of hazardous wastes. The Company has not been listed as a

key pollutant discharge entity by the environmental protection authority. In 2025

* Direct emissions (Scope 1) encompass emissions directly generated by the Company through the consumption of fossil fuels including gasoline diesel and natural

gas as well as direct emissions resulting from escape of refrigerant. Indirect emissions (Scope 2) include emissions resulting from the consumption of purchased the Company did not violate any environmental law or regulation and was not

electricity by the Company. Total emissions represent the aggregate of direct and indirect emissions. The accounting methodology for electricity emission factors primarily

references the national average CO2 emission factor for electricity outlined in the "Announcement on Release of 2023 CO2 Emission Factor for Electricity" issued by the

subject to administrative penalties by the environmental protection authority.Ministry of Ecology and Environment of the People's Republic of China on Dec. 31 2025. Additionally calorific value coefficients and emission factors for other energy

sources are mainly derived from the "Guidelines for Compiling Provincial Greenhouse Gas Inventory" and the "General Rules for Calculation of the Comprehensive Energy

Consumption".

63 64Environmental and Occupational Health and Safety Management Addressing Climate Change Green Operation Environmental and Occupational Health and Safety Management Addressing Climate Change Green Operation

Emissions and waste management >

The Company places emphasis on fostering water conservation awareness among all employees. Through various means

Wastewater management such as posting water conservation slogans in office areas and sending internal notices we advocate employees adopting

All sewage undergoes treatment following the principles of "rain and sewage diversion collection at source and reuse". good water-saving habits and guide them to embrace the concept of "taking pride in saving water and feeling ashamed of

Snibe implements environmentally friendly sewage management practices. Wastewater is categorized into rainwater wasting it" collectively creating a green low-carbon and resource-conserving office environment.domestic sewage and production wastewater by source. Following a classified management approach we collect each type

of wastewater accordingly. The sources of liquid medical waste and air filtration wastewater are collected and managed Focusing on water conservation and efficiency improvement we proactively optimize water management measures. By

by accredited facilities. Meanwhile the reject water without any chemical reagents and additives generated during the scientifically adjusting the operating pressure of water supply equipment and rationally controlling the water pressure

preparation of purified water is directed to a dedicated reject water recovery pool for toilet flushing and park irrigation and and volume of faucets in restrooms water consumption is effectively reduced without compromising employees' normal

discharged from the municipal domestic wastewater pipe network into the Shatian Water Purification Plant contributing to water needs. This also reduces the operating load of basement water supply equipment achieving dual benefits of water

resource conservation and waste reduction. conservation and equipment maintenance. In the Company's daily operations the reject water generated mainly comes from

the purified water preparation process. The quality of this reject water has been tested and fully complies with the "Reuse of

Waste gas management Urban Recycling Water — Water Quality Standard for Urban Miscellaneous Use" (GB/T 18920-2020). Adhering to the principle

All waste gases produced by the Company are subject to the principle of "classified collection centralized treatment and of resource conservation and waste reduction we have installed reject water storage tanks for recycling and reuse. Currently

standards-compliant discharge". The production waste gases are treated through the waste gas treatment facility to meet 100-cubic-meter and 180-cubic-meter reject water storage tanks have been installed to supply water for toilet flushing and

regulatory standards before discharge with regular emissions testing conducted. Independent waste gas collection covers park irrigation in the Company's Phase II and Phase III parks respectively effectively reducing tap water consumption.and fume hoods are installed in production workshops and locations or areas where waste gas is generated within each

production line. The waste gas treatment device is equipped with activated carbon boxes and spray towers to ensure that We prioritize water balance testing as a cornerstone of water resource management and conduct systematic testing

laboratory waste gas is discharged in compliance with environmental standards. The flow directions in waste gas collection data collection and analysis to establish precise water usage equilibrium. By scrutinizing every aspect of water usage

pipelines are clearly marked and regular testing of waste gas by third-party institutions ensures alignment with relevant and optimizing processes with data-driven insights we ensure stable operations while maximizing water efficiency and

laws and regulations on emissions. conservation.Waste management In 2025 the Company's total water

Snibe has established a dedicated task force for environmental pollution prevention and control to perform classified intake amounted to 250223 cubic Volume of reject water

management of medical and hazardous wastes. Medical wastes including infectious waste sharps waste and chemical Total water intake Water intake intensity recoveredmeterswith a water intake intensity

waste are centrally collected in specialized medical waste bins and then disposed of by accredited facilities. The ten types of 0.5467 cubic meters per 10000 250223 0.5467 21679.7

of hazardous wastes including waste activated carbon waste engine oil waste lamp tubes waste circuit board waste yuan and 21679.7 cubic meters of 3

thermometer waste ink carbon ribbon waste rust-proof oil waste chemicals waste packaging and spray tower wastewater cubic meters m /10000 RMB cubic metersreject water recovered.are centrally transported and disposed of by third-party organizations after collection.Energy management

The Company actively implements the requirements for solid waste pollution prevention and control fully promotes the The Company actively controls the rational use of energy continuously enhances energy efficiency through technological

domestic waste classification system and continuously advances the refined and eco-friendly management of solid wastes. advancements equipment upgrades and various measures and strengthens the publicity and practice of green concepts to

For general solid wastes (domestic waste kitchen waste etc.) generated in daily operations the Company strictly implements maximize energy efficiency.classified management and entrusts qualified third-party organizations to carry out standardized transportation utilization

and disposal. At the same time the Company rigorously reviews the technical capabilities of the entrusted parties to ensure To ensure electricity safety we prioritize core facilities such as generator sets and power supply and distribution systems

full-process compliance. Recyclable materials such as office waste paper and cardboard are handed over to professional in routine inspections and conduct comprehensive maintenance regularly. Through continuous routine inspections and

recycling facilities for resource utilization. preventative maintenance we focus on operating conditions and circuit safety and promptly replace aging or damaged parts

and components to eliminate safety hazards at the source and ensure the stable and efficient operation of the power system.To further enhance employees' awareness of waste classification and improve the accuracy of waste disposal the Company A comprehensive survey of primary secondary and terminal power distribution cabinets is conducted and standardized

continuously optimizes the classification facility configuration and signage within its premises. For domestic waste and signs are posted to clearly distinguish between daily and emergency power supplies preventing the emergency power

kitchen waste on each floor the layout and specifications of bins have been specially upgraded to improve their visibility supply from being occupied and enabling rapid identification and response during emergencies.and ease of disposal. A regular waste battery recycling mechanism has been established with dedicated recycling bins

placed at fixed locations. The waste battery collection and disposal process has been standardized to reduce the potential We strengthen energy-saving awareness among all employees by posting slogans and sending notices to promote behaviors

environmental impact of heavy metals and other pollutants. such as saving electricity double-sided printing turning off lights when leaving saving water and actively reporting water

leaks. Signs are posted on switches and air conditioner panels to remind employees to use air conditioners scientifically: set

Resource and energy management > to no lower than 26 ° C in summer and no higher than 20 ° C in winter. Employees are guided to start with small actions and

jointly create a green office environment.Water resource management

The Company rigorously regulates water resource usage increases the proportion of recycled water and enhances water We continuously promote refined management by scientifically regulating air conditioning units and reasonably setting

resource utilization efficiency through measures like water recycling and equipment adjustments. parameters based on seasonal changes and office needs. While ensuring office comfort this approach maximizes

A regular inspection and maintenance mechanism for water facilities has been established and imp operational efficiency and reduces power consumption achieving a balance between comfort and energy efficiency. For key

roved incorporating key water facilities such as domestic water tanks and solar hot water systems into routine inspections. areas such as the Phase III plant's special workshops and underground garages the lighting on/off times and brightness are

Comprehensive inspections and maintenance are carried out regularly focusing on facility operation stability and pipeline scientifically adjusted to eliminate the phenomenon of "lights left on all the time" ensuring efficient use of lighting resources.sealing. Aging or damaged parts and components such as valves pipes and faucets are replaced promptly to eliminate A centralized control device is installed at charging stations of underground garages which is linked with the mobile phone

leaks at the source ensuring that all facilities remain in good working condition thereby guaranteeing water safety and to set a scheduled shutdown time thereby avoiding a potential safety hazard and power waste caused by long-term standby

efficiency. A remote smart meter has been installed on the master water meter to monitor the water consumption in real time charging. The time-controlled system is deployed for courtyard lights parking lot lights and LOGO lights in the parks

through the intelligent system so as to effectively avoid manual meter reading errors quickly detect abnormal water use enabling precise remote control via mobile phones to significantly reduce energy consumption. Solar panels are regularly

and timely troubleshoot water leaks or equipment failures. cleaned and maintained to improve thermal conversion efficiency and maximize green energy benefits.

65 66Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety

04 Attraction and Retention of Talents

TALENT

EMPOWERMENT

Major issues Diversity and equal employment >

· Diversity and equal employment

· Employee rights and benefits Equal employment

· Employee training and developmentt In strict accordance with laws and regulations such as the "Labor Law of the People's Republic of China" and "Labor Contract

· Occupational health and safety Law of the People's Republic of China" Snibe has formulated internal systems such as the "Human Resources Control

Procedure" "Employee Handbook" "Employee Internal Transfer Management System" and "Intern Management System"

to standardize the recruitment and talent management process and build a high-quality and diversified talent team. It

is clearly stated in the "Human Resources Control Procedure" that Snibe prohibits the employment of child labor opposes

discrimination in gender health and age advocates diversity and offers equal opportunities for every employee and

Alignment with Sustainable Development Goals (SDGs) job seeker. It is also explicitly specified in the "Anti-Discrimination and Anti-Harassment Management System" that Snibe

prohibits unfair treatment of employees in the process of recruitment training promotion etc. on the basis of race social

class nationality religion disability gender etc.In 2025 Snibe embraced a "hard worker focused" concept for exploration and practice in such fields as talent organization

and management workplace environment corporate culture remuneration and welfare and training system. For the first

time we built and launched a LinkedIn Life page shaping ourselves into a quality employer. In addition we received the

honor of "2025 Employer of Excellence in Occupational Credit" from Guangzhou Best Check Human Resources Co. Ltd.Attraction and reserve of talents

Snibe values a well-layered talent pipeline by formulating comprehensive talent development strategies and exploring

flexible and diverse ways to absorb talents. On-campus and off-campus recruitment are two major ways Snibe brings in

needed talents.For on-campus recruitment we persist in working with universities on university-enterprise cooperation projects and

ensuring ongoing communication. At present we have signed university-enterprise cooperation agreements with top

Talent is the core driving force for sustainable corporate development. Snibe domestic universities and built internship & practice bases. Nearly 600 faculty members and students have visited Snibe in

consistently prioritizes its talent strategy as the key to overall development the past year. By establishing joint postgraduate bases and employment bases as well as joint post-doctoral research bases

continuously advances the construct ion of the employer brand and and employment bases and holding lectures on career development in colleges and universities we continue to deepen

comprehensively enhances the professional level of human resource management. the university-enterprise cooperation and have established long-term cooperation with many colleges and universities to

Embracing an open and inclusive philosophy we have established diversified provide internship opportunities for their students. There are more than 150 interns in the Company. We provide one-on-

talent recruitment mechanisms while protecting the legitimate rights and interests one mentorship for interns who join early and prioritize full-time conversion opportunities for students who have excellent

of employees according to laws. By establishing a sound vocational training system practice performance. These cooperation programs allow us to offer various practice and employment opportunities to

and clear career development channels we create a fair and transparent growth university students and help them transform theoretical knowledge into practical skills. In turn this provides us with access to

platform for employees and fully stimulate organizational innovation vitality. We a huge talent pool.continuously improve the occupational health safety management and welfare

systems and better bind employees and bring them happiness so as to achieve

the value creation and common growth of the enterprise and its employees.

68Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety

Employee rights and benefits >

To recruit off-campus talents we not only work with mainstream recruitment platforms and experienced headhunting

institutions at home and abroad but also encourage our employees to recommend potential candidates. An array of talent Remuneration and welfare system

introduction channels helps to fuel our talent-driven development foster a team of scarce cutting-edge talents and integrate To establish a fair and competitive remuneration system effectively attract retain and motivate talent and support the

excellent talents to fulfill our strategic goals. achievement of strategic goals and sustainable development the Company has formulated the "Employee Remuneration

Management System" providing employees with a competitive remuneration system. The Company implements a

Employee diversity remuneration system based on job value and performance results. The total annual remuneration of an employee consists of

Snibe remains committed to building a workplace of diversity equality and tolerance. With a diversified and inclusive "monthly base salary + allowances/subsidies + performance bonus". In addition we provide employees with annual salary

recruitment policy we gather together top talents from across the world and encourage employees with different adjustment opportunities and reward teams and individuals who are dedicated to their work have outstanding abilities and

backgrounds to give full play to their talents. We treat every employee equally and secure their rights and interests in achieve remarkable results in recognition of their exceptional contributions to the Company.recruitment promotion development remuneration and welfare regardless of gender age race nationality etc.According to national and local regulations we ensure that our employees are entitled to statutory holidays and leaves

We actively cultivate a diverse workforce and champion workplace inclusivity. We focus on empowering underrepresented contribute to social insurance and housing accumulation fund for all employees and provide comprehensive non-salary

groups and providing employment opportunities for individuals with disabilities. To respect the religious and cultural benefits including supplemental commercial insurance annual checkups health testing and consultation festival activities

differences of foreign employees we provide dedicated prayer rooms in the Company and assist foreign employees in and team-building activities to meet employees' physical and mental health needs. For our female employees we not only

obtaining legal work permits and residence permits to ensure their legal employment in China. We offer re-employment provide paid marriage leave maternity leave breastfeeding leave and other holidays stipulated by national laws to female

opportunities for retired employees. Retirees are welcomed back and provided with competitive benefits while fully employees of reproductive years but also build baby care rooms for working mothers offer yoga classes and hold Women's

considering the operational needs. Day and Mother's Day activities.By the end of 2025 Snibe had 2785 employees with 168 from minority groups of whom 36.62% were female and 30.27% of

managerial positions were held by women.Statutory Benefits Employee Welfare Work-life Balance

● Statutory holidays ● Holiday allowance ● Library

● Statutory leaves including sick leave work ● Staff quarters ● Gym

injury leave marriage leave funeral leave ● Staff canteen ● Yoga class

Male Male prenatal check-up leave maternity leave ● Shuttle bus ● Basketball court

63.38% 69.73% paternity leave breastfeeding leave and ● Annual lottery ● Team-building activities

Employees by Management by

Female gender Female gender annual leave ● Commemorative gift ● Festival activities

36.62% 30.27% ● Social insurance including pension ● Activity funds ● Club activities

medical insurance unemployment insurance ● Assistance in employee's settling ● Amateur cultural activities

work-related injury insurance maternity down

insurance etc. ● Supplemental commercial

● Housing accumulation fund insurance

● Other statutory benefits ● Occupational health examination

● Health consultation hotline

30 years old or below Associate's degree or below Health lectures and free medical

58.42% 26.73% clinics

31–40 years old Bachelor's degree

35.73% 52.42% By the end of 2025 we have signed labor contracts with and paid social insurance for 100% of our employees.

Employees by

41–50 years old Employees by Master's degree

age educational 5.35% 20.43% background

Over 50 years old Doctor's degree

0.50% 0.43% Work-life balance

Snibe cares about employees' life after work and offers a variety of cultural activities and holiday care activities. All

employees are encouraged to participate in such activities. Employee activities include:

69 70Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety

● Snibe organizes online and offline activities during traditional holidays annual celebrations and annual meetings. During Employee care and communication >

festivals such as Women's Day Dragon Boat Festival and Mid-Autumn Festival special activities are successively held

including gamified check-in challenges skincare classes plaster printmaking and lantern making. This year marked the Establishing multi-dimensional communication channels

Company's 30th anniversary. We organized a series of activities including a fun sports meeting and a themed marketplace Snibe values listening to employees' voices and fully respects their opinions and feedback. To facilitate communication

produced a 30th-anniversary promotional video successfully completed the unveiling ceremony of the corporate culture between employees and the management Snibe builds feedback platforms of different types at all levels for equal efficient

spiritual fortress and the departmental tree adoption activity and customized anniversary T-shirts refrigerator magnets and and constructive communication within the Company.exclusive name tags for all employees further enhancing employees' sense of participation honor and belonging.We conducted an annual satisfaction survey for all employees covering eight dimensions: their own work internal

● To promote the inheritance of Snibe's culture and the realization of its strategy and to commemorate the hard work and communication and management career development work environment and office software remuneration and welfare

dedication of "Snibers" this year we held an award ceremony for employees serving the Company for 15 years and above and corporate culture industry environment and company development and overall satisfaction. This year the employee

presented them with service commemorative coins and trophies. Commemorative coins were also given to employees who satisfaction rate was 89.2%. Through systematic categorization and data analysis of survey results we identified that

had served the Company for 1 3 5 and 10 years. To foster a culture of relentless pursuit of excellence the Company convened employees' concerns were primarily concentrated in three areas: remuneration and benefits their own work as well

the 2025 Annual Performance Review & Honors Gala to formally recognize individuals and teams who delivered exceptional as management and communication. This provides a data foundation and decision-making basis for further improving

impact on mission-critical initiatives this year. management and services. Based on employee feedback we will continuously optimize our initiatives enhance employee

satisfaction and well-being and work together with employees to create a better working environment.● To help employees relax and keep fit Snibe has built an in-house gym a yoga room a library a basketball court etc.and employed external professional yoga teachers to regularly conduct yoga classes at the Company. In addition football

and badminton courts rented outside the Company are also available on a regular basis providing a platform for employees Feedback Platform Feedback and Communication Mechanism

to keep fit and enrich their spare time. In collaboration with culture and sports authorities we organize free events such

as watching movies and stage plays fostering a harmonious and healthy work atmosphere and continuously enhancing Employee Satisfaction We conduct an annual satisfaction survey for all employees and report the pooled

employee well-being. Survey survey results to the Company's management. Relevant departments are tasked with

implementation and progress tracking based on the Company's decisions.● This year we held a Family Day event for the first time inviting employees' family members to visit the company tour the

workplace and experience the corporate culture thereby strengthening family support for employees and enhancing their Regular Feedback Through our year-end performance appraisal process we systematically gather the

sense of identification. In conjunction with the Pingshan District Party-Mass Service Center we organized several employee Collection opinions or suggestions of all employees on all aspects of the Company's management

social events to build a communication and dating platform for young singles deepening the humanistic care for young and report them to the management with designated departments tasked with

people. implementation and progress tracking. We collect feedback and recommendations

from new employees and reply to them through symposiums and other forms. We

● To help new employees get familiar with the parks quickly better adapt to the corporate culture and enhance sense of also interview employees who intend to leave to improve the talent retention plan in a

belonging we presented the "Guide to Park Life" and explained it in person on the day of employment. We organized a targeted manner.welcome party for fresh graduates to help them better know each other and blend in with the big family of Snibe.Smart Park Platform We continue to optimize the Snibe Smart Park Online Platform and encourage employees

to give feedback on the staff canteen equipment repair and various park services

through the platform.In-house Publication "The Snibers" an in-house magazine serves as the main medium to promote corporate

culture and highlight our employees. It includes such columns as company news

management policies employees showcase reflections on work the voice and spare

time life which focus on listening to employees and uniting all together.Dedicated Feedback A dedicated feedback email and an anonymous submission portal are available for

Women's Day activities Mid-Autumn Festival lantern making Commemorative Coin Award Ceremony Email and Anonymous employees to voice concerns or proposals. Management responses to substantive

Submission Portal suggestions will be fed back to the employees.Department Meetings Heads of each department stay informed of employees' demands through department

meetings and annual performance talks.Labor Union and Employees' Congress

The labor union at Snibe forms a bridge of communication between the management and general employees. The

Unveiling of corporate culture spiritual Anniversary basketball game Welcome party for fresh graduates Employees' Congress aims to protect the rights interests and welfare of employees and keep the company dynamic. The

fortress

71 72Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety

Labor Union regularly holds the Employees' Congress as required and maintains close communication with all employees to We keep improving and optimizing various training systems and processes. Committed to "people-oriented making the

get them involved in the decision-making of important affairs. Rules and regulations are also being optimized and improved best use of everyone's abilities" we have put in place a training operation system that focuses on both "talent construction"

to better safeguard the rights and interests of employees. and "product empowerment". A diverse training system of all layers and categories is being built along with talent training

mechanisms of all types to fuel the internal business operation at all positions. A combination of both online and offline

In 2025 the Company held the Employees' Congress two times to review and approve systems such as the "Technical Grade training including onboarding induction/transfer training external expert-led management training special training for

Evaluation Measures for Engineers in Domestic and Foreign Technical Service Departments" and the "Management Measures serving staff and special training on quality instrumentation and safety production improves employees' hard and soft skills

for the Professional Knowledge and Skills Assessment of Product Managers in the Domestic Market Department" further and overall workplace capabilities drives their career development supports the Company's ongoing business expansion and

improving the talent evaluation and cultivation system. At the same time the Congress successfully completed the election optimization and shapes a talent pipeline for continuous business development.of employee representative directors to the Company's board of directors effectively guaranteeing employees' rights to

participate in the Company's democratic management and supervision. In 2025 we offered 33899 training opportunities of 96743 hours for our employees.Talent introduction and retention for 2025:

Employee ability improvement >

New Employees Turnover Rate * All-round ability improvement

We have been developing and upgrading training courses that target and serve the company's development strategy and

212 8.21% business needs.

● Cultivation of fresh graduates

We have established a training framework for fresh graduates including three stages: "entry" "growth" and "success". Group

training after joining the company helps new employees to get the basics of the company swiftly learn and adapt to the

corporate culture and complete the transformation from campus to workplace. Tutoring job rotation and panel discussions

enable fresh graduates to quickly fit into the team and master essential job skills. With the guidance of the direct supervisor

and tutors these new employees can establish a solid groundwork for independently undertaking key tasks in the future.● General knowledge and soft skills enhancement

Product basics popularization and work-related comprehensive soft skill enhancement are realized through Snibe Lecture

with the help of an online learning platform "DingTalk". Through years of continuous exploration and experimentation we

have initially established a framework for general workplace knowledge and skills training. This year we launched 37 online

courses across five series: AI communication and presentation medical science popularization summary and reporting and

four major chronic diseases. For the first time we successfully repurposed online courses into offline courses which became

highly popular upon release. A total of 40 sessions were held throughout the year with more than 6300 attendances and an

Employee Training and Development average learning time of approximately one hour per person meeting employees' learning needs for general skills.● Improved management capabilities

We have comprehensively strengthened the reserve and development of mid-level and frontline managers. This year

we focused on carrying out special training on personnel management capabilities for the marketing team. For overseas

marketing centers we specially hired external experts to conduct a 3-day full-time intensive training themed "Building High-

Performance Cross-Cultural Teams — Talent Identification and Utilization in Sales Teams". The training comprehensively

Training system > imparted experience and skills in talent "selection utilization development retention and motivation" to managers from four

dimensions: "managing goals managing processes managing capabilities and managing willingness" thereby enhancing

Diverse training system the management capabilities of the marketing team. For the domestic marketing center a two-day full-time intensive training

Snibe believes that employee training boosts the corporate development. On top of the "Training Management System" themed "Annual Goal Management and Efficient Execution Workshop" was conducted by rehiring external experienced

Snibe has formulated a series of training management measures detailed rules and operational guidelines such as the experts. The training covered four aspects: "understanding and upgrading of the manager's role goal management and plan

"Operational Guidelines for the Implementation of Training Process" and the "Operational Measures for the Implementation execution team development and motivation as well as communication skills and practical application". Managers were

of Training System" to support and standardize training. guided to engage in deep learning and self-reflection supplemented by learning methods such as scenario simulations and

role-playing which reinforced the training outcomes.● Enhancement of professional skills

Leveraging our part-time internal trainer team and the "Cloud Classroom" online platform we have launched a series

* Turnover rate = annual employee departures/average annual headcount

73 74Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety

of training programs including "Product Optimization and Upgrade" "Performance Verification" "Annual Rotational Qualification and talent recognition

Training" and "New Product Empowerment" thereby meeting employees' professional learning needs and solidifying their We have been developing and upgrading training courses that target and serve the company's development strategy and

understanding and knowledge of new products. This year we have further expanded training programs on the themes business needs.of "Quality Instrumentation and Safety" the "Medical Device Assembler·Job Level Certification" series and the "Reagent

Production Quality and Efficiency Improvement" special program to meet employees' more refined deeper and broader ● Support for employee qualification

needs for professional upgrading. What's more we actively communicate with industry experts suppliers and other partners Snibe encourages and rewards all employees to take the exams for relevant skills certificates and gain post qualifications by

and host activities like "Clinical Testing Lecture" "Snibe Day" and "Inspection Industry Experts/Specialized Exchange Meeting" covering all associated costs including exam fees and annual reviews. Employees participating in off-job training can also

to further meet the learning needs of personnel in specific functions/positions for "advanced specialized cutting-edge" get subsidies of transportation catering etc. By the end of 2025 employees had obtained more than 100 skill certificates

knowledge and provide support and momentum for internal technical reformation and product innovation. covering professional skill qualification certifications in fields such as special equipment safety internal audit medical device

lifecycle management drug validation electronic product testing statistical technology application metrological verification

In addition we provide employees with more opportunities and platforms for learning and growth by investing more and and standard substance development chemical management corporate compliance and occupational health.more in talent cultivation and integration. In 2023 we were officially certified as a "Shenzhen High-skilled Talents Training

Base". In 2024 we received the "Top Ten Demonstration Carriers of Shenzhen Lifelong Vocational Skills Training" award from ● Assistance in talent recognition and professional title application

the Human Resources and Social Security Bureau of Shenzhen Municipality. These recognitions offer a promising platform for We assist qualified employees in applying for high-level talent recognition and professional titles under the talent policies of

future employee development and talent cultivation. local governments and we encourage employees to further their professional competitiveness. We also hold skills festivals

with Shenzhen colleges and universities to identify the field-operational experts with excellent skills. In 2025 54 employees in

the Company obtained professional titles in their respective fields.Employee promotion and development >

Diverse promotion and development paths

To "make the best use of talents" we set up clear and detailed promotion channels for employees with a series of clear internal

promotion systems including the "Rank Management Measures" "Rank Promotion Management Measures for Reagent R&D

Personnel" "Supplementary Rules for Promotion and Management of R&D Personnel" "Technical Grade Evaluation Measures

for Engineers in Domestic and Foreign Technical Service Departments" "Rank Promotion Management Measures for Product

Managers in Domestic Marketing Departments" etc. At the same time the Rank Evaluation Committee the highest authority

for rank promotion and development has been established to ensure fair reasonable scientific and compliant selection.Snibe aspires to grow with employees together and set position requirements in line with the corporate goals and employee

career goals. Clear exact and fair career paths have been designed for employees of all ranks and all positions. We

encourage employees to leverage their talents and challenge new positions. We set three career development paths of

"expertise" "management" and "business" to provide fair and impartial career choices and development opportunities for

all employees. With the promotion method integrating "technical expertise" and "management ability" employees with

outstanding contributions or special talents are promoted more than one grade at a time while employees with exceptional

comprehensive and professional ability are promoted and cultivated so as to guide employees to leverage their own edges in

enhancing professional skills and overall competitiveness.To promote talent mobility we implement a flexible internal transfer mechanism regularly monitor and evaluate the

work performance and professional skills of employees who wish to transfer and provide appropriate support. We offer

cross-departmental and cross-functional transfer opportunities to employees who are willing and qualified to transfer

breaking down job restrictions stimulating employee development potential and enhancing organizational vitality and

innovation capabilities. Moreover we continue to optimize the talent management by adjusting the existing rank evaluation

requirements so that employees can have a clearer understanding of their development direction. The talent analysis report

and human resources management report of each center are regularly output so as to timely identify and motivate employees

with outstanding work performance.In 2025 100% of employees received year-end performance appraisals and more than 80 employees applied for and

completed internal transfer.

75 76Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety

Employee Career Development System

Occupational Health and Safety

Employee Career Employee

career development career

level path/level/ development

appraisal standard planning

Occupational health >

Snibe believes in "people first" in its management and always puts employee health in the first place. Various measures

are taken to safeguard the physical and mental health of employees. The Company strictly abides by relevant laws and

regulations on occupational health and safety like the "Safety Production Law of the People's Republic of China" and

Where am I Career Where to go

development path How to go the "Law of the People's Republic of China on the Prevention and Control of Occupational Diseases" and has developed

management systems such as the "Control Procedure for Hazards" the "Management System for the Prevention and Control

of Occupational Diseases" and the "Work-related Injury Management System" to identify analyze and manage potential risks

in daily operations and protect the health and safety of employees.Employee Promotion Channels

Deaths from Serious injuries from Occupational injuries excluding Losses of working hours due

occupational injury occupational injury deaths and serious injuries to occupational injuries

Management path Professional Business

technology path path 0 0 7 1779 hours

Deputy general

manager Chief engineer

Deputy general manager

of marketing center

Occupational disease prevention and control

Director/deputy Regional deputy Snibe continuously regulates occupational health monitoring to prevent occupational diseases. The Human Resources Staff engineer

director director/director Department conducts statistical analysis and management of occupational hazards. During employee onboarding the

department truthfully informs employees about the occupational disease hazards associated with their positions including

Manager/deputy potential consequences protective measures and relevant benefits. The Company implements occupational disease

manager Senior engineer Regional manager prevention measures and requires employees to sign the "Job-Specific Occupational Disease Hazards Notice".Intermediate The Company sets up bulletin boards in prominent positions in the production workshops to issue rules and regulations on the Supervisor engineer District manager prevention and control of occupational hazards operating procedures emergency rescue measures for occupational hazards

accidents and the detection and evaluation results of occupational hazards in the workplace. The Company organizes

occupational health examinations for employees who are exposed to occupational disease hazards and special operations in

Team leader/specialist Engineer Sales manager strict accordance with the relevant regulations based on the types of occupational disease hazards and the level of exposure.The physical examination report is added to personal health records and the employee is informed of the actual results of

occupational health examination.Assistant/trainee Safeguarding physical and mental health

The Company places a strong emphasis on the physical and mental health of its employees regularly organizes occupational

health checkups and routinely conducts activities such as traditional Chinese medicine health lectures free clinic services

New employee and stress relief workshops. In collaboration with commercial insurance providers the Company also offers health screenings

including retinal scans and TCM pulse-taking machine assessments. A mental health hotline has been established to support

employees' overall well-being.To ensure the hygiene of food and the safety of drinking water in the Company canteen all canteen staff are required to be

77 78Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety Attraction and Retention of Talents Employee Training and Development Occupational Health and Safety

certified and regularly inspect food quality and hygiene. Key aspects of the food service process are managed through record- drills comprehensively covered key risk scenarios. In addition to emergency drills such as fire evacuation hazardous chemical

keeping forms to ensure full traceability. In addition a food safety emergency plan has been developed and procedures for accidents highly toxic substances and hazardous waste pollution disposal we also organized specialized emergency

handling emergencies have been clearly defined. Regarding drinking water clear testing standards and limit values for water drills such as dormitory fire emergency drills heptafluoropropane gas extinguishing system emergency drills and elevator

tanks and direct drinking fountains have been established. The Company regularly commissions external agencies to test accident emergency drills. These drills effectively strengthen the emergency response awareness and practical handling

water quality. Direct drinking fountains are cleaned at regular intervals and their filters are replaced to ensure that drinking capabilities of all personnel.water complies with the national standards for drinking water quality.Safety management >

Snibe always regards safe production as the lifeline of enterprise development and unswervingly implements the

responsibility system for safe production. To fortify safety safeguards the Company conducts regular safety awareness

campaigns and training programs. These initiatives systematically elevate employees' safety consciousness through multi-

dimensional and in-depth approaches comprehensively enhance their occupational safety competencies and effectively

reduce various safety risks.Strengthening the foundation of safety

In terms of safety training and awareness building the Company has established an education mechanism of "mandatory

training upon onboarding + annual refresher training". This year a total of 6 special safety training sessions for new employees

and 2 safety retraining sessions for all employees were conducted achieving full coverage of all positions. By leveraging

key occasions such as "Safety Production Month" and "Fire Prevention Publicity Month" and through various forms such as

knowledge lectures and case studies we create a cultural atmosphere where "everyone talks about safety" continuously

strengthen the safety awareness and sense of responsibility among all employees and build a solid ideological defense. Emergency Response Drill for Hazardous Chemical Leaks

In terms of special equipment safety operation and maintenance the Company has established a management system In May 2025 we conducted a special drill for hazardous

covering the entire lifecycle of equipment strictly implements the daily inspection and regular maintenance system for chemical leaks in key areas such as hazardous chemical

elevators and completes the review and verification of special equipment safety standardization certificates and the updating warehouses and hazardous waste storage rooms.of technical files to ensure that the equipment is always in a compliant safe and reliable operating state eliminating Prior to the drill more than 1000 personnel including

potential hazards from the source. warehouse managers operators and emergency

response team members received systematic training

At the level of fire safety management the Company thoroughly implements the working policy of "prevention first which focused on the hazardous characteristics of

combining prevention and firefighting" continuously optimizes the configuration of fire protection facilities establishes a chemicals safety identification and emergency

"daily inspection monthly testing and annual maintenance" mechanism and regularly conducts equipment function tests. response procedures for leaks. The drill simulated

The Company strictly abides by the national regulations and standards to ensure that the fire passages in the office area are the entire process of a leak accident including its

unblocked and standard fire protection facilities and equipment are well equipped. Designated personnel is responsible for occurrence reporting initial response and evacuation

conducting regular inspections to eliminate potential safety hazards in a timely manner. effectively strengthening the risk prevention and

collaborative response capabilities of key personnel.In terms of hazardous goods management the Company strictly implements effective control measures for hazardous

goods. We properly classify store and protect various chemicals flammable and explosive materials according to their

specific characteristic. Hazardous chemical warehouses are equipped with adequate protective equipment fire protection

and emergency response facilities and have obvious warning signs. Hazardous chemicals are classified according to their Extreme Weather Emergency Response

characteristics and SDS documents are stored in the corresponding hazardous chemical storage cabinet which is managed

and registered by designated personnel in accordance with the regulations. Hazardous goods are counted by warehouse In Sep. 2025 Super Typhoon Ragasa struck. The

keeper on a quarterly basis. Administration Department responded swiftly forming

an emergency task force and inspection teams. We

In terms of emergency management the Company establishes an emergency preparedness and response mechanism. We adhere to source control thoroughly clean up sewers in

clearly define emergency response plans for various types of accidents including fires hazardous chemical accidents and advance reinforce objects on the ground and rooftops

object strikes. In accordance with the requirements of the emergency plans we equip ourselves with emergency supplies and build a solid safety barrier. At the same time we

equipment or facilities and designate the persons responsible for their daily storage and inspection. In terms of emergency strengthened routine precautions conducted regular

resource allocation we form a first-aider team and equip medical kits and first-aid equipment among others. In terms lightning protection inspections regularly maintained

of emergency evacuation the signage management of safety exits and evacuation routes in office and production areas generator sets and worked with professional third-

should be fully standardized to ensure that escape routes are clearly identifiable. The responsibilities of the floor supervisors party maintenance organizations to issue professional

and evacuation guides are clearly defined establishing a well-defined emergency command system that provides a solid maintenance reports to ensure the safety and reliability

guarantee for the rapid and orderly evacuation of personnel in emergency situations. of emergency facilities and equipment.Emergency drills and response

The Company consistently implements its emergency response plan system for safe production. In 2025 we organized more

than 20 emergency drills and specialized training sessions to enhance our practical emergency response capabilities. These

79 80Industry Exchange and Cooperation Community Commonweal

05 Industry Exchange and Cooperation

FULFILLING SOCIAL

RESPONSIBILITY

Industry-University-Research collaboration and multi-center research >

Major issues

· Industry exchange and cooperation In active response to the "14th Five-Year Plan for Pharmaceutical Industry Development" and the "Healthy China 2030

· Community commonweal Planning Outline" Snibe has continuously focused on addressing the pain points and needs of front-line clinical and

laboratory medicine and attached great importance to industry-university-research-hospital-application cooperation.Snibe has joined hands with universities hospitals and enterprises for all-round cooperation targeting disease diagnosis

and treatment medical technology development IVD research and development technology commercialization and talent

training. By leveraging respective strengths all parties aim to promote product diversification and technological innovation

in IVD. Amidst the national endeavor to prevent and control the four major non-communicable diseases Snibe has carried

out relevant research with medical institutions to help early diagnosis and treatment of chronic diseases.Alignment with Sustainable Development Goals (SDGs)

Multi-center Research on Screening of Aldosterone and Renin in Patients

with Primary Aldosteronism Establishment of Diagnostic Cut-off Values

and Clinical Application Evaluation

On Mar. 29 2025 the "Multi-center Research on

Screening of Aldosterone and Renin in Patients with

Primary Aldosteronism Establishment of Diagnostic

Cut-off Values and Clinical Application Evaluation" and

the " Multi-center Research on Aldosterone and Renin

Reference Interval Establishment in Different Regions of

China" participated in and supported by the Company

While steadily advancing its own development Snibe has never were concluded in Shenzhen. This multi-center

forgotten to fulfill its corporate social responsibility. Relying on our research has promoted the standardization of primary

competencies and technological expertise we actively participate aldosteronism screening and diagnosis in China and

in industry exchanges and cooperation promote the popularization will help to further promote primary aldosteronism

of medical examination knowledge and facilitate the overall screening at the grassroots level.development of the industry. We collaborate with multiple medical

institutions to conduct scientific research promote early diagnosis

and treatment of chronic diseases and continuously support scientific

research and education contributing our efforts to the training of

diagnostic personnel and the advancement of medical research.

82Industry Exchange and Cooperation Community Commonweal Industry Exchange and Cooperation Community Commonweal

Academic extension >

Multi-center Research on the Clinical Application of High-sensitivity Supporting chronic disease management and value-based healthcare practices

Troponin I Concentration and Changes in the Assessment of Acute China's healthcare system is undergoing profound changes. The comprehensive advancement of DRG/DIP payment reform

Myocardial Infarction marks a shift in the healthcare value evaluation system from "payment based on quantity" to "pricing based on effectiveness" and the concept of value-based healthcare is gradually gaining popularity. The Company fully leverages its leading position

in the field of laboratory medicine to promote the exploration and practice of chronic disease management and value-based

On Apr. 19 2025 the Company held a launch meeting healthcare. In 2025 the Company continued to conduct a number of chronic disease management activities and the relevant

in Nanjing for the "Multi-center Research on the Clinical conference convened experts and scholars from the field of laboratory medicine to discuss in depth the strategies cutting-

Application of High-sensitivity Troponin I Concentration edge concepts latest technologies and practical challenges of disease prevention and treatment aiming to promote the

and Changes in the Assessment of Acute Myocardial accurate diagnosis and clinical management of chronic diseases and contribute to the high-quality development of chronic

Infarction" in which it participated and supported. This disease management in China. "Appropriate and precise" solutions are provided for achieving the strategic goals of "Healthy

multi-center research will combine machine learning China 2030".algorithms to transform static data into time-series

dynamic multi-modal diagnostic models and develop Participating in the preparation of laboratory medicine books and clinical manuals

more flexible accurate and more suitable diagnostic As the editor-in-chief Snibe participated in the preparation of "Medical Laboratory Equipment and Application" (immunology

solutions for the Chinese population. This also marks a section biochemistry section laboratory intelligence and informatization section) "Expert Consensus on the Development

new milestone for the Company in the field of clinical and Evaluation of In Vitro Diagnostic Products" and "In Vitro Diagnostic Enterprise Operation and Management" led by

application research of myocardial biomarkers. renowned experts in Chinese laboratory medicine transforming our technical accumulation in chemiluminescence

biochemistry automated assembly line reagent research and development laboratory intelligence construction and other

fields into standardization knowledge and consensus. Through the authoritative and practical guidance of these publications

the Company promotes the standardization of industry technology makes the research and evaluation of in vitro diagnostic

products more in line with current needs and contributes to the high-quality publication of innovative textbooks for the

cultivation of medical laboratory technology professionals under the background of new medicine.In active response to the national policy on optimizing test panel profiles the Company takes the lead in compiling the

"Handbook for Conducting Clinical Test Items" to assist medical institutions in conducting truly meaningful and clinically

valuable test items as well as enabling precision testing for related disease screening treatment and prognosis thus

empowering value-based healthcare.Real-World Research on the Establishment of a Spectrum of Endocrine

System Toxicity Related to Tumor Immunotherapy and Its Impact on Patient Supporting clinical academic research

Clinical Outcomes By the end of 2025 Snibe users worldwide had published over 600 international journal articles and approximately 200

academic posters related to Snibe products. Snibe has partnered with several authoritative hospitals to conduct 16 medical

studies on its small molecule "Snibe-NACA" testing product and 25 related academic papers have been published to date.On Dec. 14 2025 our Company launched a "Real- Extensive real-world customer research data shows that the "Snibe-NACA" testing technology effectively addresses clinical

World Research on the Establishment of a Spectrum pain points and facilitates precise disease diagnosis and treatment.of Endocrine System Toxicity Related to Tumor

Immunotherapy and Its Impact on Patient Clinical Popularizing laboratory knowledge

Outcomes" in collaboration with 20 top-tier tertiary Actively promoting the popularization of clinical medical knowledge is an important part of our social responsibility as a

hospitals. This multi-center research promotes a biopharmaceutical company. We popularize laboratory medicine knowledge through professional articles popular science

profound shift in cancer treatment from "disease- posters and online professional knowledge exchanges.centered" to "patient-centered" by systematically

constructing a toxicity management model. The Company in collaboration with DXY conducted online academic exchanges through medical forums and organized 13

offline academic exchange conferences to popularize knowledge of laboratory medicine and promote industry exchange and

cooperation.

83 84Industry Exchange and Cooperation Community Commonweal Industry Exchange and Cooperation Community Commonweal

Driving industry standardization >

Deeply engaging in the development of standardization organizations

The Company actively participates in the development of industry standardization organizations takes the initiative to

participate in the work of standardization technical committees at all levels and actively applies for committee member

qualifications using its professional capabilities to help the industry and standardization work achieve high-quality

development. In 2025 the Company successfully joined two national and international counterpart standardization technical

organizations: Rao Jie was selected as a member of the WG3 (In Vitro Diagnostic Products Group) of the domestic technical

counterpart working group for ISO/TC212 Medical Laboratories and In Vitro Diagnostic Systems and Du Kai was selected as

a member of the TC136 Clinical Laboratory Testing and In Vitro Diagnostic Test Systems. Leveraging its role as a committee

member the Company will participate more deeply in industry standardization efforts and continue to contribute its

professional expertise to the industry's standardization and high-quality development.Engaging in standards development and standard system establishment and revision

Snibe actively integrates itself into both domestic and international standardization systems. The Company not only

participates in the research of national and international standards but also contributes to the formulation of national

standards industry standards and group standards in an all-round way. With excellent professional capabilities and

extensive industry experience Snibe demonstrates its leadership in facilitating the mutual recognition of test results.During the reporting period the Company engaged in the development and collaborative calibration of 20 national

standards national references and international standards led or participated in the drafting of 11 reagent-related

national standards industry standards and group standards and established 1 reference method further strengthening

the traceability consistency and result mutual recognition of the aforementioned diagnostic products. By doing so scientific

In 2025 the Company's overseas marketing department leveraged the Company's self-owned media platforms to promote norms and guidance are in place for the industry development effectively promoting the standardization process of the

laboratory medicine knowledge through promotional posters on the occasion of major global health awareness days thereby industry.fulfilling its corporate social responsibility.During the reporting period the development of standards and references as well as the compilation of national/industry/

group standards that Snibe is involved in include:

Type Assay Abbreviation Name Status

National HCG Human chorionic gonadotropin Collaborative assignment uniformity and

standards stability tests completed; released.FSH Follicle-stimulating hormone Collaborative assignment uniformity and

stability tests completed; to be released.TSH Thyroid stimulating hormone Collaborative assignment uniformity and

stability tests completed; released.tPSA Total prostate-specific antigen Collaborative assignment completed; to be

released.fPSA Free prostate-specific antigen Collaborative assignment completed; to be

released.IGF-1 Insulin-like growth factor-1 Periodic verification experiment completed

TNF-α Tumor necrosis factor-alpha Collaborative assignment completed; to be

released.IL-6 Interleukin-6 Collaborative assignment completed; to be

released.

17α-OHP 17 α-hydroxyprogesterone Collaborative assignment and suitability study

completed; to be released.

85 86Industry Exchange and Cooperation Community Commonweal Industry Exchange and Cooperation Community Commonweal

Type Assay Abbreviation Name Status Type Name Sponsor Status

National PROG Progesterone Collaborative assignment and suitability Industry Cortisol testing kit Clinical Laboratory Testing and We participated in standard

standards study completed; to be released. standard In Vitro Diagnostic Test Systems drafting and the standard

formulation (SAC/TC136) was submitted for approval.TEST Testosterone Collaborative assignment and suitability

study completed; to be released. Group standard Vascular endothelial growth factor China Inspection and Testing We participated in standard

formulation assay kit (magnetic particle based Society drafting and the standard

ALD Aldosterone Assignment and application preparation chemiluminescent immunoassay) was released in Jul. 2025.stage

Immunoassay - evaluation of Chinese Society for We participated in standard

National Anti-HCV Hepatitis C virus antibody Collaborative assignment completed; to be measurement uncertainty Measurement drafting and the standard

references released. was submitted for approval.CMV IgM Cytomegalovirus IgM Collaborative assignment completed; to be Guidelines for construction and China Association of Productivity We participated in standard

antibody released. evaluation of smart laboratory Part Promotion Centers drafting and the standard

2: Medical laboratory was released in Jan. 2025.

B19 IgM Human parvovirus B19 IgM Collaborative assignment completed; to be

antibody released. Technical requirements for Hospital Management and As the deputy editor-in-chief

information technology Information Technology we participated in standard

Toxo IgM Toxoplasma gondii IgM Collaborative assignment completed; to be construction of regional medical Construction Branch of the writing; drafting in progress.antibody released. laboratories National Association of Health

Industry and Enterprise

Rubella IgM Rubella virus IgM antibody Collaborative assignment completed; to be Management

released.Fully-Auto Chemiluminescence Standardization Working We participated in standard

HBs Ag Hepatitis B surface antigen Collaborative assignment completed; to be Immunoassay Analyzer Committee of China Association drafting and the standard

(chemiluminescence) (chemiluminescence) released. for Promoting International was submitted for approval.Economic & Technical

HBs Ag (rapid test) Hepatitis B surface antigen Collaborative assignment completed; to be Cooperation

(rapid test) released.Establishment Development of a standard National Center for Clinical The method has been

International TNF-α Tumor necrosis factor-alpha Collaborative assignment completed; to be of test reference reference method for FT3/FT4 Laboratories Guangdong established and validated;

standards released. method small molecule free hormones Provincial Hospital of Traditional the article is in the process of

by liquid chromatography-mass Chinese Medicine publication.spectrometry

Type Name Sponsor Status

National Automatic sample processing system for Clinical Laboratory Testing We participated in standard

standard medical use and In Vitro Diagnostic Test drafting and the standard

formulation Systems (SAC/TC136) was released in Oct. 2025.In vitro diagnostic medical devices Clinical Laboratory Testing We participated in standard Driving laboratory quality management standardization

— Information supplied by the and In Vitro Diagnostic Test drafting and the standard Laboratory quality management and testing competency serve as fundamental safeguards for achieving inter-institutional

manufacturer (labelling) — Part 1: Terms Systems (SAC/TC136) was submitted for approval.definitions and general requirements consistency in diagnostic outcomes forming the essential basis for mutual recognition of test results. ISO 15189 is currently

the most authoritative international standard for accreditation of medical laboratories. Guided by national policies the

Industry 17 α-hydroxyprogesterone assay kit Clinical Laboratory Testing We led the standard drafting Company has launched a standardized laboratory construction solution which covers ISO 15189 accreditation services

standard (labeled immunoassay) and In Vitro Diagnostic Test and the standard was quality supervision services and grassroots quality improvement services comprehensively covering the multi-dimensional

formulation Systems (SAC/TC136) released in Jun. 2025. standardized construction needs of laboratories and promoting the "standardization" of laboratories.In vitro diagnostic medical devices — Clinical Laboratory Testing We participated in standard

Practical guidance for establishing and In Vitro Diagnostic Test drafting and the standard To promote the adoption of ISO 15189 certification ISO 15189 training and guidance were provided to 82 hospitals in 2025

metrological traceability of values — Part Systems (SAC/TC136) was submitted for approval. of which 87% were tertiary hospitals. The Company continues to improve service solutions driving the standardization in the

1: Traceable to SI field of health care and intelligent laboratory construction and the implementation of the "test results mutual recognition

strategy".Blood ammonia test kit Clinical Laboratory Testing We participated in standard

and In Vitro Diagnostic Test drafting and the standard

Systems (SAC/TC136) was submitted for approval.

87 88Industry Exchange and Cooperation Community Commonweal Industry Exchange and Cooperation Community Commonweal

laboratory medicine in underdeveloped regions. We have systematically shared in vitro diagnostic solutions and localization

practices suitable for resource-constrained environments and held practical discussions on key issues such as improving

the capabilities of primary laboratories optimizing public health screening networks and strengthening personnel training

Medical laboratory accreditation and quality management training course and technology transfer. By building an open and collaborative dialogue platform Snibe is committed to promoting the

widespread availability of appropriate technologies facilitating knowledge sharing and capacity building in the field of

laboratory medicine between China and Africa and contributing professional expertise to improving healthcare accessibility

In Ju l . 2025 the "Medical Laboratory Qual i ty in underdeveloped regions such as Africa and contributing to global health equity and accessibility.Management Training Course and ISO 15189 Internal

Auditor Training Course" hosted by the Guangdong

Association of Chinese Integrative Medicine was held

at the company headquarters to help promote the

standardized construction of the medical laboratory

quality management system improve the laboratory's

quality management and technical capabilities

and help medical institutions achieve high-quality

development.International exchanges and cooperation >

In Dec. 2025 Snibe's representatives participated in a In Nov. 2025 during the China-Africa Medical Development

Strategic cooperation forum panel discussion at the WHX Leaders in Ghana. Forum held in Tunisia the Tunisian Minister of Health visited

Snibe's booth.In 2025 we signed strategic cooperation memorandums with health departments of governments and authoritative

laboratory medicine associations in more than 20 countries around the world and added partners in Latin America Central

Asia and Oceania. The types of signing institutions have also expanded from mainly professional associations to a wider

range of fields such as governments enterprises universities and international alliances. This move signifies the Company's

deepening cooperation and increasing influence in the international laboratory medicine field and will help promote the

further dissemination and popularization of high-quality in vitro diagnostic products. Community Commonweal

Support for research and education >

Supporting scientific work

We actively fulfill our corporate social responsibilities by

contributing our fair share to promote inclusive diagnostic

knowledge advance sustainable laboratory development

cultivate diagnostic talent and support education and medical

research. Supporting the development of

On Mar. 30 2025 Hon. Kwabena Minitah Akandoh Minister On Oct. 26 2025 Dr. Raiva Simbi Minister of Health of In 2025 the Company officially became an official sponsor public healthcare

of Health of Ghana and Ms. Liu Haiyan Deputy General Zimbabwe and Ms. Liu Haiyan Deputy General Manager of of the EFLM GREEN LABS program deeply involved in and

Manager of Snibe jointly signed a strategic cooperation Snibe jointly signed a strategic cooperation memorandum supporting this important industry initiative that promotes

memorandum in Shenzhen. in Shenzhen. the sustainable development of clinical laboratories. Initiated In Oct. 2025 in order to promote the development

by the EFLM "Green and Sustainable Labs Committee" this of public health and medical services and advance

program is dedicated to promoting the transformation of scientific research on laboratory medicine-related

Supporting clinical testing in countries of the Belt and Road Initiative laboratory medicine into a sustainable healthcare system. It programs the Company donated RMB 500000

Snibe actively responds to the "Belt and Road" initiative vigorously advances business expansion in Africa and is committed aims to make efficient use of resources from ecological social to the Zhong Nanshan Medical Foundation of

to strengthening China-Africa cooperation in the process of "going global" to achieve mutual benefit and win-win results. and economic dimensions reduce energy consumption water Guangdong Province.waste and the use of hazardous chemicals while ensuring

We actively participate in the China-Africa Health Cooperation Forum working with health officials medical institution the quality of medical services and help Europe achieve its

representatives and industry experts from various African countries to focus on the development path and future planning of carbon neutrality goal by 2050.

89 90Industry Exchange and Cooperation Community Commonweal Industry Exchange and Cooperation Community Commonweal

We closely follow the outstanding young researchers and scientists emerging in the fields of clinical chemistry and laboratory

medicine. Through our continuous support of the IFCC Young Investigator Award and the IFCC Distinguished Award for

Laboratory Medicine and Patient Care we recognize and encourage young scholars who have made outstanding scientific

achievements in the fields of clinical chemistry and laboratory medicine as well as individuals who have made unique

contributions to improving patient care and generating global impact in the field of clinical medicine.Sponsoring outstanding young researchers

On May 14 2025 at the opening ceremony of Euromedlab in

Brussels Snibe participated in and supported the IFCC Young

Investigator Award as a special sponsor of this important award. On Mar. 21 2025 Snibe held a seminar on laboratory On Jun. 28 2025 Snibe held a seminar on laboratory

The award aims to recognize young scholars under the age of medicine in Kenya. medicine in Ethiopia.

40 who have made outstanding scientific achievements in the

fields of clinical chemistry and laboratory medicine. This year's

laureate is Dr. Christopher Farnsworth. Ms. Liu Haiyan Deputy

General Manager of Snibe was invited to present awards to Supporting community commonweal >

the laureate further showcasing Snibe's corporate image and

professional influence to industry experts and clients in Europe As a listed biopharmaceutical company with a strong sense of social responsibility and national commitment the Company

and around the world. has always deeply integrated corporate social responsibility into its development strategy and proactively shouldered its

social responsibility mission.Education is of paramount importance to both the country and the Party. Snibe attaches great importance to the high-quality

development of education and actively engages in science popularization and public welfare education contributing to the

vigorous development of socialist education with practical actions. In 2025 the Company was awarded the title of "Science

Popularization Education Base" by the Science and Technology Innovation Bureau for its solid practice and outstanding

contributions in the field of science popularization education which further consolidated the foundation of science

popularization education work. Upholding its commitment to social responsibility the Company has carried out science

Empowering global diagnostics talents popularization and education activities. In 2025 it hosted teachers and students from Pingshan Foreign Language School

The Company is keenly aware of the importance of technical cooperation and has carried out a number of academic and Shenzhen Pingshan Eastern Greater Bay Experimental School for visits and exchanges totaling more than 60 visits. This

exchange activities in Africa in recent years regularly inviting well-known lecturers to share their laboratory techniques provided students with a window to understand cutting-edge technologies and industry development in the field of medical

and industry experience. These activities have enhanced the diagnostic and treatment capabilities of local medical staff devices effectively stimulating young people's interest and enthusiasm for scientific exploration and the biomedical field and

promoted mutual learning and exchange of medical technologies and strengthened in-depth interaction between the two fulfilling the Company's responsibility for science popularization and education.sides in their professional fields.At the same time in response to the national rural revitalization strategy the Company has actively participated in rural

revitalization public welfare undertakings donated RMB 10000 to the Pingshan District Charity Association and contributed

to rural development with practical donations conveying corporate warmth and demonstrating the responsibility and

commitment of a national biopharmaceutical company.On Apr. 24 2025 Snibe co-hosted the Snibe Day On Mar. 14 2025 Snibe held a seminar on laboratory

international academic lectures on laboratory medicine medicine in Tanzania.with the International Federation of Clinical Chemistry and

Laboratory Medicine (IFCC) in Algeria.

91 92Key Performance Indicator Table Key Performance Indicator Table

Economic Indicators Water resource

Indicator Unit 2023 2024 2025 Indicator Unit 2023 2024 2025

3

Operating revenue 10000 RMB 392965.57 453540.45 457675.95 Water intake m 235533 244266 250223

3

Cost of operations 10000 RMB 106247.60 126653.49 140724.23 Water intake intensity m / 10000 RMB 0.5994 0.5386 0.5467

Total Value of Assets 10000 RMB 822248.88 961945.35 994075.80 Volume of reject water recovered m

319396.8020870.1021679.70

Asset-liability ratio % 8.25 10.84 8.01

Net profit attributable to shareholders Waste

10000 RMB 165365.32 182845.66

of listed companies 162025.22 Indicator Unit 2023 2024 2025

EPS RMB/share 2.1054 2.3271 2.0621 Biohazard waste Tons 95.50 149.3 122.32

Hazardous waste Tons 0.88 2.08 2.81

Environmental indicators General industrial solid waste Tons 51.60 87.00 211.46

Greenhouse Gas Emissions

Indicator Unit 2023 2024 2025 Environmental compliance

Direct emissions (Scope 1) Tons of CO2 equivalent 452.82 1138.78 2589.96 Indicator Unit 2023 2024 2025

Indirect emissions (Scope 2) Tons of CO2 equivalent 12288.54 14213.66 14481.52 Total monetary value of significant fines RMB 0 0 0

Total emissions (Scope 1 and 2) Tons of CO2 equivalent 12741.36 15352.44 17071.48 Total number of non-monetary sanctions Cases 0 0 0

Carbon emission intensity per unit Tons of CO2 equivalent/10000 Cases brought through dispute settlement mechanisms Cases 0 0 0

of revenue RMB revenue 0.0324 0.0339 0.0373

Energy source

Indicator Unit 2023 2024 2025 Social indicators

Purchased electric power kWh 21735492.00 26480307.55 27281049.87 Diversity and equal employment

Natural gas consumption m3 51093.00 55181.00 51719.00 Indicator Unit 2023 2024 2025

Diesel consumption Tons 12.60 12.09 9.89 Number of staff involved Persons 2627 2841 2785

Gasoline consumption Tons 27.30 27.33 25.16 Male employees % 64.94 63.57 63.38

Direct energy consumption Tons of standard coal 120.57 124.84 114.23 Female employees % 35.06 36.43 36.62

Indirect energy consumption Tons of standard coal 2671.29 3254.43 3352.84 Male employees in management % 70.71 69.05 69.73

Total energy consumption Tons of standard coal 2791.86 3379.27 3467.07 Female employees in management % 29.29 30.95 30.27

Energy consumption intensity Tons of standard coal/ 10000 RMB 0.0071 0.0075 Employees under 30 years old % 62.31 62.44 58.42 0.0076

93 94Key Performance Indicator Table Key Performance Indicator Table

Diversity and equal employment Occupational health and safety

Indicator Unit 2023 2024 2025 Indicator Unit 2023 2024 2025

Employees aged 30-40 years old % 33.80 33.09 35.73 Deaths and mortality rate of employee caused by work injury Persons;% 0 0 0

Employees aged 40-50 years old % 3.43 4.05 5.35 Occupational injuries excluding deaths and serious injuries Persons 5 6 7

Employees over 50 years old % 0.46 0.42 0.50 Losses of working hours due to occupational injuries Hours 635.04 1773.04 1779

College degree or below % 29.62 27.49 26.71

Anti discrimination

Undergraduates % 52.87 52.76 52.42

Indicator Unit 2023 2024 2025

Postgraduates % 17.24 19.43 20.43

Total number of discrimination incidents during the reporting period Cases 0 0 0

PhD students % 0.27 0.32 0.43

Quality of product and service

Attraction and Retention of Employees

Indicator Unit 2023 2024 2025

Indicator Unit 2023 2024 2025 Quality management system certification Pcs 3 3 3

Number of new employees Persons 594 563 212

External regulatory review Times 5 6 5

Turnover Rate % 12.49 9.56 8.21

Third party quality system audit Times 7 8 8

Employee compensation and benefits Overall satisfaction with customer complaint handling % 100 100 100

Indicator Unit 2023 2024 2025 Events where fines or penalties are imposed for violations of regulations Cases 0 0 0

Employee labor contract signing rate % 100 100 100 Events subject to warnings due to violations of regulations Cases 0 0 0

Employee social insurance coverage rate % 100 100 100 Events that violated the voluntary code Cases 0 0 0

Events of Product recall quantity Pcs 0 0 0

Employee training and development

Indicator Unit 2023 2024 2025 Product R&D

Total training duration Hours 164366 86482 96743

Indicator Unit 2023 2024 2025

Total number of trainees Times 33109 13298 33899

Total number of R&D personnel Persons 693 836 781

Occupational health and safety R&D investment amount 10000 RMB 36604.71 45358.80 47776.93

Indicator Unit 2023 2024 2025 Cumulative number of patent applications Pcs 523 629 743

Investment amount in environmental and occupational health & safety 10000 RMB / 409.5 458 Valid patents granted Pcs 335 388 426

Coverage rate of occupational health examination % 100 100 100 Valid invention patents granted Pcs 142 169 197

Chemiluminescence immunoassay reagent projects provided globally Items 199 224 250

95 96Key Performance Indicator Table Appendix

Supplier management

Issue Index of "Shenzhen Stock Exchange Self-Regulation Guidelines for Listed

Indicator Unit 2023 2024 2025 Companies No. 17 - Sustainable Development Report (Trial)"

Total number of new suppliers Suppliers 35 36 50

Number of suppliers disqualified due to quality issues Suppliers 0 4 4

Dimension No. Issue Section

Percentage of the Chinese Mainland suppliers % 95.21 95.90 96.30

Environment 1 Addressing Climate Change Addressing Climate Change

2 Pollutant emissions Green Operation

Marketing management

3 Waste disposal Green Operation

Indicator Unit 2023 2024 2025

Events where fines or penalties are imposed for violations of regulations Cases 0 0 0 4 Ecosystem and biodiversity conservation /

Events subject to warnings due to violations of regulations Cases 0 0 0 5 Environmental compliance management Environmental and occupational health and safety management

Events that violated the voluntary code Cases 0 0 0 6 Energy utilization Addressing Climate Change

7 Water utilization Green Operation

Customer privacy

8 Circular economy Green Operation

Indicator Unit 2023 2024 2025

Society 9 Rural revitalization Community Commonweal

The total number of confirmed leaks theft or loss of customer information Cases 0 0 0

10 Social contribution Industry exchange and cooperationCommunity Commonweal

The total number of confirmed complaints received regarding violations of customer privacy Cases 0 0 0

11 Innovation-driven development Focusing on R&D and Innovation

Anti-corruption 12 Ethics of science and technology Focusing on R&D and Innovation

Indicator Unit 2023 2024 2024 13 Supply chain security Supply Chain Management

Number of anti-commercial bribery trainings Times 8 19 14 14 Equal treatment of SMEs Supply Chain ManagementResponsible Marketing

Proportion of employees receiving anti-commercial bribery trainings % 100 100 100 15 Safety and quality of products and services Product Quality and SafetyCustomer Service Quality

Proportion of employees signing anti-commercial bribery commitments % 100 100 100 16 Data security and customer privacy protection Compliance in Operation

17 Employees Attraction and Retention of Talents Employee Training

and DevelopmentOccupational Health and Safety

Governance 18 Due diligence Compliance in Operation

related to

sustainable 19 Communications with stakeholders ESG governance

development

20 Anti-commercial bribery and anti-corruption Compliance in Operation

21 Anti-unfair competition Responsible Marketing

97 98Appendix Appendix

GRI Index Table

Indicator No. Indicator Name Report Chapter Indicator No. Indicator Name Report Chapter

GRI2：General Disclosures 2-27 Compliance with laws and regulations REGULATING CORPORATE GOVERNANCESTRICTLY

CONTROLLING THE QUALITY OF PRODUCTS AND

SERVICESTALENT EMPOWERMENTPROMOTING GREEN

The organization and its reporting practices OPERATIONAppendix

2-1 Organizational details ABOUT THIS REPORT Stakeholder engagement

2-2 Entities included in the organization’s sustainability reporting ABOUT THIS REPORT 2-29 Approach to stakeholder engagement ESG governance

2-3 Reporting period frequency and contact point ABOUT THIS REPORT GRI3：Mater ial Topics

2-4 Restatements of information ABOUT THIS REPORT Key Performance Indicator Table 3-1 Process to determine material topics ESG governance

Activities and workers 3-2 List of material topics ESG governance

2-6 Activities value chain and other business relationships Supply Chain ManagementResponsible MarketingCustomer Service Quality 3-3 Management of material topics ESG governance

2-7 Employees Attraction and Retention of Talents GRI201：Economic Performance

Governance 201-1 Direct economic value generated and distributed Key Performance Indicator Table

2-9 Governance structure and composition Corporate governance 201-2 Financial implications and other risks and opportunities due to climate change Addressing Climate Change

2-10 Nomination and selection of the highest governance body Corporate governance GRI203：Indirect Economic Impacts

2-11 Chair of the highest governance body Corporate governance 203-1 Infrastructure investments and services supported Community Commonweal

2-12 Role of the highest governance body in overseeing the management of impacts Corporate governance GRI204：Procurement Practices

2-14 Role of the highest governance body in sustainability reporting ESG governance 204-1 Proportion of spending on local suppliers Supply Chain Management

2-16 Communication of critical concerns ESG governance　 GRI205：Anti-corruption

2-17 Collective knowledge of the highest governance body Corporate governance 205-2 Communication and training about anti-corruption policies and procedures Compliance in Operation

2-18 Evaluation of the performance of the highest governance body Corporate governance GRI206：Anti-competitive Behavior

2-20 Process to determine remuneration Corporate governance 206-1 Legal actions for anti-competitive behavior anti-trust and monopoly practices Key Performance Indicator Table

Strategy po licies and practices GRI302：Energy

2-22 Statement on sustainable development strategy MESSAGE FROM THE CHAIRMAN 302-1 Energy consumption within the organization Addressing Climate ChangeKey Performance Indicator Table

2-23 Policy commitments Compliance in Operation 302-3 Energy intensity Addressing Climate Change

2-24 Embedding policy commitments Compliance in Operation Supply Chain ManagementResponsible Marketing 302-4 Reduction of energy consumption Addressing Climate Change

2-25 Processes to remediate negative impacts Compliance in Operation 302-5 Reductions in energy requirements of products and services Addressing Climate ChangeKey Performance Indicator Table

2-26 Mechanisms for seeking advice and raising concerns Compliance in Operation

99 100Appendix Appendix

Indicator No. Indicator Name Report Chapter Indicator No. Indicator Name Report Chapter

GRI303：Water and Effluents 403-3 Occupational health services Environmental and occupational health and safety

management Occupational Health and Safety

303-1 Interactions with water as a shared resource Green Operation

403-4 Worker participation consultation and communication on Employee care and communication

303-2 Management of water discharge-related impacts Green Operation occupational health and safety

303-3 Water withdrawal Green Operation Key Performance Indicator Table 403-5 Worker training on occupational health and safety Environmental and occupational health and safety

management Occupational Health and Safety

303-4 Water discharge Green Operation

403-6 Promotion of worker health Environmental and occupational health and safety

GRI305：Emissions managementOccupational Health and Safety

305-1 Direct (Scope 1) GHG emissions Addressing Climate Change Key Performance Indicator Table 403-7 Prevention and mitigation of occupational health and safety Environmental and occupational health and

impacts directly linked by business relationships safety management

305-2 Energy indirect (Scope 2) GHG emissions Addressing Climate Change Key Performance Indicator Table

403-8 Workers covered by an occupational health and safety Environmental and occupational health and

305-4 GHG emissions intensity Addressing Climate Change Key Performance Indicator Table management system safety management

GRI306：Effluents and Waste 403-9 Work-related injuries Occupational Health and Safety

Key Performance Indicator Table

306-1 Waste generation and significant waste-related impacts Green Operation

GRI404：Training and Education

306-2 Management of significant waste-related impacts Green Operation

404-1 Average hours of training per year per employee Employee Training and DevelopmentKey

306-3 Waste generated Green Operation Performance Indicator Table

306-5 Waste directed to disposal Green Operation 404-2 Programs for upgrading employee skills and transition assistance Employee Training and Development

programs

GRI308：Supplier Environmental Assessment

404-3 Percentage of employees receiving regular performance and Employee Training and Development Key

308-1 New suppliers that were screened using environmental criteria Supply Chain Management career development reviews Performance Indicator Table

308-2 Negative environmental impacts in the supply chain and actions Supply Chain Management GRI405：Diversity and Equal Opportunity

Society 405-1 Diversity of governance bodies and employees Corporate governance Attraction and Retention

of Talents Key Performance Indicator Table

GRI401：Employment

GRI406：Non-discrimination

401-1 New employee hires and employee turnover Attraction and Retention of TalentsKey Performance Indicator Table

406-1 Incidents of discrimination and corrective actions taken Attraction and Retention of Talents

401-2 Benefits provided to full-time employees that are Attraction and Retention of Talents Employee Training and Development Key Performance Indicator Table

not provided to temporary or part-time employees

GRI416：Customer Health and Safety

GRI403：Occupational Health and Safety

416-1 Assessment of the health and safety impacts of product and Product Quality and Safety Customer

403-1 Occupational health and safety management system Environmental and occupational health and safety management service categories Service Quality

403-2 Hazard identification risk assessment and incident investigation Environmental and occupational health and safety GRI417：Marketing and Labeling

management Occupational Health and Safety

417-1 Requirements for product and service information and labeling Responsible Marketing

101 102Shenzhen New Industries Biomedical Engineering Co. Ltd.

Add: Snibe BuildingNo.23 Jinxiu East Road Pingshan District Shenzhen P.R. China

Web: www.snibe.com

E-mail: snibeinfo@snibe.cn

Zip code: 518122